US20070185530A1 - Patent foramen ovale closure method - Google Patents
Patent foramen ovale closure method Download PDFInfo
- Publication number
- US20070185530A1 US20070185530A1 US11/469,653 US46965306A US2007185530A1 US 20070185530 A1 US20070185530 A1 US 20070185530A1 US 46965306 A US46965306 A US 46965306A US 2007185530 A1 US2007185530 A1 US 2007185530A1
- Authority
- US
- United States
- Prior art keywords
- septum
- closure
- closure device
- heart
- anchor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 62
- 208000008883 Patent Foramen Ovale Diseases 0.000 title abstract description 89
- 230000007027 foramen ovale closure Effects 0.000 title 1
- PPTYJKAXVCCBDU-UHFFFAOYSA-N Rohypnol Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1F PPTYJKAXVCCBDU-UHFFFAOYSA-N 0.000 claims abstract description 162
- 210000002216 heart Anatomy 0.000 claims abstract description 49
- 210000002837 heart atrium Anatomy 0.000 claims abstract description 32
- 210000004971 interatrial septum Anatomy 0.000 claims abstract description 17
- 230000001746 atrial effect Effects 0.000 claims description 40
- 230000000149 penetrating effect Effects 0.000 claims description 10
- 238000002324 minimally invasive surgery Methods 0.000 claims description 7
- 238000005553 drilling Methods 0.000 claims description 2
- 210000001008 atrial appendage Anatomy 0.000 claims 4
- 210000005245 right atrium Anatomy 0.000 description 28
- 210000005246 left atrium Anatomy 0.000 description 27
- 230000035515 penetration Effects 0.000 description 19
- 210000001519 tissue Anatomy 0.000 description 12
- 210000004491 foramen ovale Anatomy 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 238000001356 surgical procedure Methods 0.000 description 8
- 238000013461 design Methods 0.000 description 7
- 230000004927 fusion Effects 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 238000013459 approach Methods 0.000 description 5
- 208000013914 atrial heart septal defect Diseases 0.000 description 5
- 208000016448 atrial septal aneurysm Diseases 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000002439 hemostatic effect Effects 0.000 description 4
- 229910001000 nickel titanium Inorganic materials 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 208000032382 Ischaemic stroke Diseases 0.000 description 3
- 210000000709 aorta Anatomy 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000005240 left ventricle Anatomy 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 210000005241 right ventricle Anatomy 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 208000005189 Embolism Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 208000032109 Transient ischaemic attack Diseases 0.000 description 2
- 210000001765 aortic valve Anatomy 0.000 description 2
- 210000003157 atrial septum Anatomy 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000009530 blood pressure measurement Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 239000013013 elastic material Substances 0.000 description 2
- 210000003191 femoral vein Anatomy 0.000 description 2
- 210000002458 fetal heart Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 210000005244 lower chamber Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 230000004088 pulmonary circulation Effects 0.000 description 2
- 239000012781 shape memory material Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 201000010875 transient cerebral ischemia Diseases 0.000 description 2
- 210000005243 upper chamber Anatomy 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000005166 vasculature Anatomy 0.000 description 2
- 206010003226 Arteriovenous fistula Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010014498 Embolic stroke Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000035478 Interatrial communication Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000001910 Ventricular Heart Septal Defects Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 210000002376 aorta thoracic Anatomy 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000000788 chromium alloy Substances 0.000 description 1
- QTCANKDTWWSCMR-UHFFFAOYSA-N costic aldehyde Natural products C1CCC(=C)C2CC(C(=C)C=O)CCC21C QTCANKDTWWSCMR-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 238000003331 infrared imaging Methods 0.000 description 1
- ISTFUJWTQAMRGA-UHFFFAOYSA-N iso-beta-costal Natural products C1C(C(=C)C=O)CCC2(C)CCCC(C)=C21 ISTFUJWTQAMRGA-UHFFFAOYSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 210000004115 mitral valve Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229940127216 oral anticoagulant drug Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000011422 pharmacological therapy Methods 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 210000005247 right atrial appendage Anatomy 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 229910000811 surgical stainless steel Inorganic materials 0.000 description 1
- 239000010966 surgical stainless steel Substances 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/08—Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0467—Instruments for cutting sutures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00592—Elastic or resilient implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00606—Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00619—Locking means for locking the implement in expanded state
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0417—T-fasteners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0419—H-fasteners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B2017/0496—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials for tensioning sutures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B2017/06052—Needle-suture combinations in which a suture is extending inside a hollow tubular needle, e.g. over the entire length of the needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
- A61B2090/064—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
Definitions
- This invention relates to devices for closing a passageway in a body, for example a patent foramen ovale (PFO) in a heart, and related methods of using such closure devices for closing the passageway.
- PFO patent foramen ovale
- Patent foramen ovale is an anatomical interatrial communication with potential for right-to-left shunting of blood.
- Patent foramen ovale is a flap-like opening between the atrial septa primum and secundum at the location of the fossa ovalis that persists after age one year.
- the foramen ovale serves as a physiologic conduit for right-to-left shunting of blood in the fetal heart.
- the septum primum (SP) against the walls of the septum secundum (SS), covering the foramen ovale and resulting in functional closure of the foramen ovale. This closure is usually followed by anatomical closure of the foramen ovale due to fusion of the septum primum (SP) to the septum secundum (SS).
- a patent foramen ovale is a persistent, usually flap-like opening between the atrial septum primum (SP) and septum secundum (SS) of a heart.
- SP atrial septum primum
- SS septum secundum
- a patent foramen ovale results when either partial or no fusion of the septum primum (SP) to the septum secundum (SS) occurs.
- PFO track a persistent passageway exists between the septum primum (SP) and septum secundum (SS).
- This opening or passageway is typically parallel to the plane of the septum primum, and has a mouth that is generally oval in shape. Normally the opening is relatively long, but quite narrow.
- the opening may be held closed due to the mean pressure in the left atrium (LA) being typically higher than in the right atrium (RA).
- LA left atrium
- RA right atrium
- the septum primum acts like a one-way valve, preventing fluid communication between the right and left atria through the PFO track.
- the pressure may temporarily be higher in the right atrium, causing the PFO track to open up and allow some fluid to pass from the right atrium to the left atrium.
- the PFO track is often held closed, the endothelialized surfaces of the tissues forming the PFO track prevent the tissues from healing together and permanently closing the PFO track.
- PFO patent foramen ovale
- Pharmacological therapy often includes oral anticoagulants or antiplatelet agents. These therapies may lead to certain side effects, including hemorrhage. If pharmacologic therapy is unsuitable, open heart surgery may be employed to close a PFO with stitches, for example. Like other open surgical treatments, this surgery is highly invasive, risky, requires general anesthesia, and may result in lengthy recuperation.
- Nonsurgical closure of a PFO is possible with umbrella-like devices developed for percutaneous closure of atrial septal defects (ASD) (a condition where there is not a well-developed septum primum (SP)).
- ASD atrial septal defects
- SP septum primum
- Many of these conventional devices used for ASD are technically complex, bulky, and difficult to deploy in a precise location. In addition, such devices may be difficult or impossible to retrieve and/or reposition should initial positioning not be satisfactory.
- these devices are specially designed for ASD and therefore may not be suitable to close and seal a PFO, particularly because the septum primum (SP) overlaps the septum secundum (SS).
- the present invention relates to a method of deploying a mechanical closure device through the septum of a heart to facilitate closing of a patent foramen ovale.
- the method comprises the steps of accessing a first atrium of the heart with a deployment device carrying the mechanical closure device.
- the mechanical closure device includes a proximal and distal anchor with a closure line attached there between.
- the deployment device is then advanced distally until the deployment device penetrates through the interatrial septum into the second atrium.
- a mechanical closure device is then introduced into the second atrium of the heart.
- the closure device is then transeptally deployed across the septum secundum and/or septum primum to provide proximation between the septum secundum and septum primum.
- the method comprises the steps of accessing a first atrium of the heart with a deployment device carrying the mechanical closure device.
- the mechanical closure device includes a proximal and distal anchor with a closure line attached there between.
- the deployment device is then advanced distally until the deployment device penetrates through at least one appendage of the interatrial septum into the second atrium.
- a mechanical closure device is then introduced into the second atrium of the heart.
- the closure device is then transeptally deployed across the penetrated interatrial septum to provide proximation between the septum secundum and septum primum.
- FIG. 1 is a short axis view of the heart at the level of the right atrium (RA) and the left atrium (LA), in a plane generally parallel to the atrio-ventricular groove, and at the level of the aortic valve, showing a PFO track.
- RA right atrium
- LA left atrium
- FIG. 2 is a cross-sectional view of the PFO track of FIG. 1 in a closed configuration.
- FIG. 3 is a close-up section view illustrating the PFO track held in the closed position by left atrial pressure.
- FIG. 4A is a cross-sectional view of the PFO track of FIG. 2 in an open configuration.
- FIG. 4B is a close-up section view illustrating the PFO track in an open configuration.
- FIG. 5A is a cross-sectional view illustrating the PFO tract of FIG. 1 .
- FIG. 5B is a section view taken along line A-A in FIG. 4B .
- FIG. 5C is a section view taken along line A-A in FIG. 3 .
- FIG. 5D is a close-up section view of the PFO track, showing the tunnel formed by the tissue extension.
- FIG. 6A is a perspective view illustrating the relationship between the components comprising the closure device and deployment device according to one aspect of the present invention.
- FIG. 6B illustrates the closure device deployed through the septum secundum and septum primum along the PFO track to close the PFO according to one embodiment of the present invention.
- FIG. 7A is a perspective view of the anchor structure in the cut pre-expanded form according to one embodiment of the present invention.
- FIG. 7B is a perspective view of the expanded anchor according to one embodiment of the present invention.
- FIG. 7C is a perspective view of the anchor under tensioning of the closure line according to one embodiment of the present invention.
- FIG. 8A illustrates substantial closure of the PFO track with the closure device deployed through the septum secundum and septum primum along the PFO track to close the PFO according to one embodiment of the present invention.
- FIG. 8B illustrates substantial closure of the PFO tract with a single penetration through both the septum primum and septum secundum according to one embodiment of the present invention.
- FIG. 8C illustrates substantial closure of the PFO track with a single penetration through the septum primum according to one embodiment of the present invention.
- FIG. 8D illustrates substantial closure of the PFO, where an ASA is present, with a single penetration only through the septum primum according to one embodiment of the present invention.
- FIG. 8E illustrates substantial closure of the PFO with a single penetration through the septum primum according to one embodiment of the present invention.
- FIG. 8F illustrates the deployment of the closure device through a single penetration in the septum secundum according to one embodiment of the present invention.
- FIG. 9A is a section view of the heart illustrating a deployment device having backup support in the form of an axially asymmetric spline according to one embodiment of the present invention.
- FIG. 9B is a section view of the heart illustrating a deployment device having backup support in the form of an axially asymmetric balloon according to one embodiment of the present invention.
- FIG. 9C is a section view of the heart illustrating a deployment device with a shape along the distal end to provide backup support, according to one embodiment of the present invention.
- FIG. 10 is a perspective view illustrating exemplary sensors, such as a hydraulic pressure port sensor and electrical pressure transducer.
- FIG. 11 is a perspective view showing the relationship between components comprising the deployment device and closure device after the needle punctures through the septum secundum and septum primum into the left atrium, according to one embodiment of the present invention.
- FIG. 12 is a perspective view showing the relationship between components comprising the deployment device and closure device after the needle retracted and the proximal device catheter, closure device and plunger are back-loaded into the distal end of the distal device catheter.
- FIG. 13 is a perspective view showing the relationship between components comprising the deployment device and closure device after the proximal device catheter is advanced along the distal device catheter and deploys the distal anchor 620 , according to one embodiment of the present invention.
- FIG. 14 is a perspective view showing the relationship between components comprising the deployment device and closure device after the proximal and distal device catheters are partially retracted back through the delivery catheter, according to one embodiment of the present invention.
- FIG. 15 is a perspective view showing the relationship between components comprising the deployment device and closure device after the delivery catheter, proximal device catheter and distal device catheter are partially retracted and the plunger advanced to deploy the proximal anchor, according to one embodiment of the present invention.
- FIG. 16 is a perspective view showing the relationship between components comprising the deployment device and closure device after the closure device is fully deployed, according to one embodiment of the present invention.
- FIG. 17 is a perspective view showing the relationship between components comprising the deployment device and closure device after the needle punctures through the septum primum into the left atrium, according to one embodiment of the present invention.
- FIG. 18 is a perspective view showing the relationship between components comprising the deployment device and closure device after the needle retracted and the proximal device catheter, closure device and plunger are back-loaded into the distal end of the distal device catheter.
- FIG. 19 is a perspective view showing the relationship between components comprising the deployment device and closure device after the proximal device catheter is advanced along the distal device catheter and deploys the distal anchor 620 , according to one embodiment of the present invention.
- FIG. 20 is a perspective view showing the relationship between components comprising the deployment device and closure device after the proximal and distal device catheters are partially retracted back through the delivery catheter, according to one embodiment of the present invention.
- FIG. 21 is a perspective view showing the relationship between components comprising the deployment device and closure device after the delivery catheter, proximal device catheter and distal device catheter are partially retracted and the plunger advanced to deploy the proximal anchor, according to one embodiment of the present invention.
- FIG. 22 is a perspective view showing the relationship between components comprising the deployment device and closure device after the closure device is fully deployed, according to one embodiment of the present invention.
- the various figures show embodiments of the patent foramen ovale (PFO) closure device and methods of using the device to close a PFO.
- PFO patent foramen ovale
- the device and related methods are described herein in connection with mechanically closing a PFO.
- These devices also are suitable for closing other openings or passageways, including other such openings in the heart, for example atrial septal defects, ventricular septal defects, and patent ducts arterioses, as well as openings or passageways in other portions of a body such as an arteriovenous fistula.
- the invention therefore is not limited to use of the inventive closure devices to close PFO's.
- a human heart has four chambers.
- the upper chambers are called the left and right atria, and the lower chambers are called the left and right ventricles.
- a wall of muscle called the septum separates the left and right atria and the left and right ventricles. That portion of the septum that separates the two upper chambers (the right and left atria) of the heart is termed the atrial (or interatrial) septum while the portion of the septum that lies between the two lower chambers (the right and left ventricles) of the heart is called the ventricular (or interventricular) septum.
- FIG. 1 illustrates a short-axis view of the heart 100 at the level of the right atrium (RA) and left atrium (LA), in a plane generally parallel to the atrio-ventricular groove, and at the level of the aortic valve. This view is looking from caudal to cranial.
- FIG. 1 also shows the septum primum (SP) 105 , a flap-like structure, which normally covers the foramen ovale 115 , an opening in the septum secundum (SS) 110 of the heart 100 .
- the foramen ovale 115 serves as a physiologic conduit for right-to-left shunting of blood in the fetal heart.
- the increased left atrial blood flow and pressure presses the septum primum (SP) 105 against the walls of the septum secundum (SS) 110 , covering the foramen ovale 115 and resulting in functional closure of the foramen ovale 115 .
- This closure is usually followed by anatomical closure of the foramen ovale 115 due to fusion of the septum primum (SP) 105 to the septum secundum (SS) 110 .
- FIG. 2 illustrates the opening of the PFO track 120 as viewed from an end of the track. Normally the opening is relatively tall, but quite narrow. The opening may be held closed by the mean pressure in the left atrium, which is typically higher than the right atrium.
- FIG. 3 is a close-up section view of the PFO track 120 held in the closed position by left atrial pressure.
- FIG. 4A is a cross-sectional view showing the PFO track of FIG. 2 in an open configuration.
- FIG. 4B is a close-up section view illustrating the PFO track in an open configuration.
- FIGS. 5A-5C (a view from line “C-C” of FIG. 1 ), the septum primum 105 is firmly attached to the septum secundum 110 around most of the perimeter of the Fossa Ovalis 115 , but has an opening along one side.
- the septum primum 105 is often connected, as shown, by two or more extensions of tissue along the sides of the PFO track 120 forming a tunnel.
- FIG. 5D is a magnified section view of the PFO track 120 , showing the tunnel formed by the tissue extensions.
- the tunnel length in an adult human can range between 2 and 13 mm.
- the present invention relates to a system and method for closing a passageway in a body.
- the device is used to close the Patent Foramen Ovale in a human heart.
- One of ordinary skill in the art would understand that similar embodiments could be used to close other passageways and openings in the body without departing from the general intent or teachings of the present invention.
- FIGS. 6A and 6B illustrate a device used to close the PFO according to one embodiment of the present invention.
- the device 600 comprises a flexible closure line 625 coupled to two expandable anchors 620 , 621 .
- Anchor 620 is coupled to distal end of the closure line 625
- anchor 621 is coupled to the proximal end of the flexible closure line 625 .
- Anchor 621 is capable of sliding along closure line 625 and locking in desired location to cinch or take-up slack in closure line 625 length, bringing the proximal and distal anchors 621 , 620 respectively, closer together and effectively bringing the septum secundum 110 and the septum primum 105 in close proximation.
- septum secundum 110 and the septum primum 105 do not have to be tightly touching to effect proper closure of the PFO. Instead, the septum secundum 110 and the septum primum 105 must just be brought close enough to minimize flow from atria to atria (typically flow from left atria to right atria).
- the locking mechanism incorporated into anchor 621 may be a device capable of allowing the closure line 625 to slide through anchor 621 in one direction, and prevent sliding movement in the opposite direction.
- Examples of functionally similar commercial locking mechanisms include the DePuy Mitek RAPIDLOCTM device; zip ties; and similar linear locking devices known in the art.
- the anchor 621 may be fixed to the closure line 625 at a predetermined distance from anchor 620 . This may particularly be the case when the closure line 625 has an elastic or recoil ability and is capable of exerting tension when deployed, pulling the anchors 620 , 621 together and effectively compressing the septum primum 105 to the septum secundum 110 .
- a closure device 600 may include an elastic closure line 625 and a slideable anchor 621 .
- the anchor 621 is capable of allowing the flexible closure line 625 to slide through the anchor 621 in one direction, and prevent sliding movement in the opposite direction, while the closure line 625 exerts tension between the two anchors 620 , 621 .
- These configurations should not necessarily be considered limiting, and other combinations of components are contemplated, such as, for example, both anchors 620 and 621 being slideable along a substantially elastic or inelastic closure line 625 .
- the closure line 625 may be any biocompatible filament known in the art that is capable of securing the septum primum 105 to the septum secundum 110 .
- the closure line 625 is a surgical suture, such as a multifilament non-biodegradable suture, or a forced entangled fiber filament.
- the closure line 625 may be made from an elastic material capable of exerting tension when stretched.
- the closure line 625 may be geometrically configured to exhibit structurally elastic behavior.
- the closure line 625 may be made from an anelastic material such as elastomeric polymers that are capable of exerting tension when stretched.
- the closure line 625 may be made from a super elastic material such as a nickel titanium alloy.
- the anchors 620 , 621 are expandable from a first, predeployed unexpanded configuration to a second expanded configuration.
- the anchors 620 , 621 are preferably constructed from a structurally deformable material.
- Structurally deformable materials are materials that can elastically or plastically deform without compromising their integrity.
- Geometric structures, such as anchors 620 , 621 , made from a deformable material are capable of changing shape when acted upon by an external force, or removal or an external force.
- Geometric structures made from structurally deformable materials are typically self expanding or mechanically expandable.
- the anchors 620 , 621 are made from a self-expanding material, such as Nitinol or a resilient polymer.
- the self-expanding anchors 620 , 621 may also be made from an elastically compressed spring temper biocompatible metals. These self-expanding structures are held in a constrained configuration by an external force, typically a capture sheath, and elastically deform when the constraining force is released.
- Geometric structures can be mechanically expanded by introduction of an external force, through, for example, a mechanical expansion means.
- Mechanical expansion means are well known in the art and include balloon or cage expansion devices.
- the structure plastically deforms to its desired final configuration.
- the anchors 620 , 621 in their constrained state are capable of being held in a restrained low profile geometry for delivery, and assume an expanded shape capable of preventing the anchor 620 , 621 from retracting through the septum primum 105 or septum secundum 110 , as the case may be, once deployed.
- the anchors 620 , 621 are cut from a Nitinol hypotube 700 by methods known in the art.
- FIG. 7A is a perspective view of the anchor 620 in the cut pre-expanded form.
- the anchor 620 is then formed into a desired expanded configuration and annealed to assume a stress-free (relaxed) state.
- the anchor 620 , 621 is formed into a basket shaped configuration, having a plurality of legs 710 .
- a perspective view of the expanded basket anchor 620 according to one embodiment of the present invention is illustrated in FIG. 7B .
- the basket shaped anchors 620 , 621 collapse under tensioning of the closure line 625 , into a flattened “flower petal” shape as illustrated in FIG. 7C .
- the anchors 620 , 621 are under strain.
- the super elastic properties of the anchors 620 , 621 under strain exert an axially outward force against the adjacent tissue, putting the closure line 625 in tension.
- FIG. 8A illustrates the closure device 600 having flower petal shaped anchors 620 , 621 deployed through the septum secundum and septum primum along the PFO tract to close the PFO according to one embodiment of the present invention.
- the proximal anchor 621 in FIG. 8A also includes a locking mechanism 622 integrated therein.
- anchors 620 , 621 should not be considered a limiting feature of the invention, as other shapes and configurations of anchors 620 , 621 are also contemplated by the present design. This may include, for example, expandable disc design, star design, j-hook design, or any expandable geometric shape. In addition other materials exhibiting similar characteristics, such as non-biodegradable swellable polymers, are similarly contemplated by the present invention. Still, other designs for anchors 620 , 621 may include long-aspect dimensioned objects axially aligned in needles 605 , 610 in the constrained state. Once deployed, the long axis of the anchor 620 , 621 rotates substantially perpendicular to the needle 605 , 610 longitudinal axis, effectively anchoring the closure line 625 in place.
- FIG. 8A illustrates the closure device 600 deployed through the septum secundum 110 and septum primum 105 along the PFO track 120 , it should be understood that the closure device 600 may be deployed through other locations to achieve the same results.
- FIGS. 8A through 8F illustrate the anchors 620 , 621 and closure line 625 in a particular orientation. It should be understood that position of the anchor structures 620 , 621 may be reversed.
- FIGS. 8B through 8F illustrate the closure device 600 deployed at various locations across the septum primum 105 and/or septum secundum 110 . Although the penetration through the septum primum 105 and/or septum secundum 110 are shown at different locations, common to each of the illustrated deployments is the location of the distal anchor 620 and the proximal anchor 621 in the left and right atrial chambers respectively.
- FIG. 8B illustrates substantial closure of the PFO tract 120 with a single penetration through both the septum primum 105 and septum secundum 110 .
- FIG. 8C illustrates substantial closure of the PFO with a single penetration only through the septum primum 105 .
- the distal and proximal anchors 620 , 621 respectively are sized to exert enough force on the septum primum 105 and septum secundum 110 to facilitate closing of the PFO track 120 when the closure line 625 is tensioned.
- the PFO closure device 600 can be used to facilitate closing the PFO track 120 when other defects in the septal wall are present.
- the PFO closure device 600 may be used when an atrial septal aneurysm (ASA) 805 is present.
- ASA is characterized as a saccular deformity, generally at the level of the fossa ovale, which protrudes to the right or left atrium, or both.
- FIG. 8D illustrates substantial closure of the PFO, where an ASA is present, with a single penetration only through the septum primum 105 .
- the distal and proximal anchors, 620 and 621 respectively are sized to contact both the septum primum 105 and septum secundum 110 to facilitate closing of the PFO track 120 .
- the single penetration method may also be employed where there is minimal overlap between the septum primum 105 and septum secundum 110 .
- This so called “short tunnel” PFO may not be readily closed with prior art “intra-tunnel methods.
- FIG. 8E illustrates substantial closure of the PFO with a single penetration through the septum primum 105 .
- the closure device 600 may be deployed using a single penetration through the septum secundum 110 as illustrated in FIG. 8F .
- the present invention utilizes a removable deployment device to introduce the mechanical closure device 600 into the atrium of the heart, preferably through a minimally invasive, transluminal procedure.
- Minimally invasive heart surgery refers to several approaches for performing heart operations that are less difficult and risky than conventional open-heart surgery. These approaches restore healthy blood flow to the heart without having to stop the heart and put the patient on a heart-lung machine during surgery. Minimally invasive procedures are carried out by entering the body through the skin, a body cavity or anatomical opening, but with the smallest damage possible to these structures. This results in less operative trauma for the patient. It also less expensive, reduces hospitalization time, causes less pain and scarring, and reduces the incidence of complications related to the surgical trauma, speeding the recovery.
- a minimally invasive procedure for performing heart surgery is a trans-thoracic laparoscopic (endoscopic) procedure.
- the part of the mammalian body that is situated between the neck and the abdomen and supported by the ribs, costal cartilages, and sternum is known as the thorax.
- This division of the body cavity lies above the diaphragm, is bounded peripherally by the wall of the chest, and contains the heart and lungs.
- the surgeon can gain access to the atrium of the heart through an atriotomy, a surgical incision of an atrium of the heart. For example, if the surgeon wishes to gain access to the right atrium they will perform an atriotomy in the right atrial appendage.
- trans-thoracic laparosopic procedure The primary advantage of a trans-thoracic laparosopic procedure is that there is no need to make a large incision. Instead, the surgeon operates through 3 or 4 tiny openings about the size of buttonholes, while viewing the patient's internal organs on a monitor. There is no large incision to heal, so patients have less pain and recover sooner. Rather than a 6- to 9-inch incision, the laparoscopic technique utilized only 4 tiny openings—all less than 1 ⁇ 2 inch in diameter.
- Percutaneous surgical techniques pertain to any medical procedure where access to inner organs or other tissue is done via needle-puncture of the skin, rather than by using an “open” approach where inner organs or tissue are exposed (typically with the use of scalpel).
- the percutaneous approach is commonly used in vascular procedures, where access to heart is gained through the venous or arterial systems. This involves a needle catheter getting access to a blood vessel, followed by the introduction of a wire through the lumen of the needle. It is over this wire that other catheters can be placed into the blood vessel. This technique is known as the modified Seldinger technique.
- the PFO closure device 600 may also be deployed via percutaneous methods by steerable catheters or guidewires.
- a peripheral vein such as a femoral vein
- the puncture wound is dilated with a dilator to a size sufficient to accommodate an introducer sheath, and an introducer sheath with at least one hemostatic valve is seated within the dilated puncture wound while maintaining relative hemostasis.
- the non-core cutting device is a tubular needle-like structure, however other configurations and shaped structures may be used as would be understood by one skilled in the art.
- the needle tube is a substantially rigid structure capable of penetrating the septum secundum 110 and septum primum 105 along the PFO track 120 .
- the needle is preferably sized to be 13 French or smaller, most preferably 10 French or smaller, and made from a biocompatible material, such as, for example surgical stainless steel, Nitinol, or Cobalt-Chromium alloys.
- the needle is constructed with a tapered distal end, as is known in the art.
- the geometric configuration of the tapered distal end is optimized to minimize induced tissue trauma at the site of penetration.
- the needle is of sufficient body length to penetrate both the septum secundum 110 and septum primum 105 , while still maintaining the needed size and axial flexibility to navigate the tortuous vessel anatomy when being delivered to the heart percutaneously.
- penetrating the interatrial septum may be accomplished by drilling through the septum.
- the guiding catheter or delivery member 630 of the closure device is introduced through the hemostatic valve of the introducer sheath and is advanced along the peripheral vein, into the region of the vena cavae, and into the right atrium.
- the distal tip of the delivery device 630 is positioned against the interatrial septal wall.
- the interatrial septal wall may be the septum primum 105 and/or septum secundum 110 , as the case may be.
- a needle or trocar associated with the delivery device 630 is then advanced distally until it punctures the septum primum 105 and or septum secundum 110 .
- a separate dilator may also be advanced with the needle through the septum primum 105 and/or septum secundum 110 to prepare an access port through the septum primum 105 and/or septum secundum 110 for seating the delivery device 630 .
- the delivery device 630 traverses across the septum and is seated in the left atrium, thereby providing access for closure devices 600 through its own inner lumen and into the left atrium.
- left atrial access methods may be suitable substitutes for using the delivery device 630 and closure device 600 of the present invention.
- a “retrograde” approach may be used, wherein the delivery device 630 is advanced into the left atrium from the arterial system.
- the Seldinger technique is employed to gain vascular access into the arterial system, rather than the venous, for example, at a femoral artery.
- the delivery device 630 is advanced retrogradedly through the aorta, around the aortic arch, into the ventricle, and then into the left atrium through the mitral valve.
- transeptally is defined as deployment from one atria to the other through the septum (septum primum 105 and/or septum secundum 110 ), as apposed to intra-atrial access through the PFO tract 120 (tunnel).
- septum septum primum 105 and/or septum secundum 110
- transeptal penetration may be through the septum primum (SP) 105 and/or septum secundum (SS) 110 , or visa versa, whichever the case may be.
- the angle of transeptal penetration is between 45 and 135 degrees to the surface of the septum, but is most preferably orthogonal to the surface of the septum.
- the right atrium is first accessed by the delivery device 630 (and closure device 600 ).
- the closure device 600 may then be deployed by penetrating the interatrial septum (septum primum 105 and/or septum secundum 110 ) from the right atrial chamber to the left atrial chamber in the heart, and deploying the distal anchor 620 associated with the closure device 600 into the left atrial chamber.
- the delivery device 630 may be partially withdrawn from the left atrial chamber to the right atrial chamber, leaving the distal anchor 620 in place.
- the proximal anchor 621 associated with the closure device 600 can then be deployed into the right atrial chamber. This substantially linear atrial deployment method is shown in FIGS. 8A through 8F .
- the left atrium is first accessed by the delivery device 630 (and closure device 600 ).
- the closure device 600 may then be deployed by penetrating the interatrial septum (septum primum 105 and/or septum secundum 110 ) from the left atrial chamber to the right atrial chamber in the heart, and deploying the distal anchor 620 associated with the closure device into the first atrium.
- the delivery device 630 may be partially withdrawn from the right atrial chamber to the left atrial chamber, leaving the distal anchor 620 in place.
- the proximal anchor 621 associated with the closure device can then be deployed into the left atrial chamber.
- the closure device may be cinched to bring the proximal and distal anchors closer together.
- the septum secundum 110 and the septum primum 105 do not have to be tightly touching to effect proper closure of the PFO. Instead, the septum secundum 110 and the septum primum 105 must just be brought close enough to minimize flow from atria to atria (typically flow from right atria to left atria).
- cinching comprises uni-axially adjusting the proximal anchor relative to a closure line associated with the closure device. In another embodiment of the invention, cinching comprises incrementally adjusting the proximal anchor relative to a closure line associated with the closure device.
- the method may further comprise assessing the degree of proximation between the septum secundum 110 and the septum primum 105 .
- the clinician may visually assess the proximation though an endoscopic or fluoroscopic procedure.
- other methods may be used to measure the proximation between the septum secundum 110 and the septum primum 105 , such as through pressure observation or infrared imaging.
- any unwanted length of closure line 625 that remains unconstrained within the right atrium may be mechanically removed.
- Devices known in the art capable of removing the excess closure line 625 include catheter-based snare and cut devices. In addition to independent devices, a mechanical cut and removal mechanism may be integrated into the deployment device.
- the closure device will then be in position, with the anchors 620 , 621 opened against the septum secundum 110 , and the closure line 625 connecting the anchors 620 , 621 through the septum primum 105 and septum secundum 110 , thus holding the septum primum 105 in place.
- Another embodiment of the invention may include a location monitoring system to facilitate placement of the deployment device 630 .
- the location monitoring device will assist in determining whether the clinician is in the correct chamber of the heart.
- the location monitoring system includes the ability to measure localized pressure relative to the distal end of the deployment device 630 .
- the pressure measurement read by the location monitoring system may be achieved by electronic, mechanical and/or physical means, such as a solid-state pressure transducer, spring loaded diaphragm, hydraulic pressure port, and/or communicating manometer. These and other pressure measurement techniques would be known by one of skill in the art.
- FIG. 10 is a perspective view illustrating exemplary sensors, such as a hydraulic pressure port 655 or electrical pressure transducer 660 .
- gage pressure in the right and left atrium are know to range from approximately 1-6 mmHg to 10 mmHg respectfully.
- gage pressure within the ascending aorta ranges from approximately 120 to 160 mmHg during systole.
- the clinician Before deployment, the clinician will first monitor pressure within the right atrium. This reading should indicate a pressure of 1-6 mmHg.
- the distal end of the outer needle 605 will be inserted through the septal wall (septum primum 105 and/or septum secundum 110 ) and into the left atrium.
- the monitored pressure should change to approximately 10 mmHg.
- the clinician will then have to retract the outer needle 605 and reposition the delivery device 630 for re-entry.
- the inner needle 610 is advanced back into the right atrium. The clinician should observe a pressure change from 10 mmHg to 1-6 mmHg.
- the deployment device 630 (and thus the closure device 600 ) is used in conjunction with an accessory device (not shown) known in the art.
- the accessory device may be a guiding catheter that tracks over a guidewire, and is steered through the vasculature into the right atrium.
- the accessory device and deployment device 630 may be formed as an integrated component, capable of being steered through the vasculature.
- the deployment device 630 may include features that provide backup support.
- This backup support may include, for example: an axially asymmetric expansion member attached along an outer shaft 635 , such as a balloon or self expanding cage 640 ; a spline 645 ; or imparting a shape 650 along the body of the deployment device 630 . Examples of these backup support features are illustrated in Figures FIGS. 9A through 9C , respectively. It should be understood that the outer shaft 635 may be part of the guiding catheter, or integrated into the deployment device 630 . These and other such backup support devices would be understood by one of skill in the art. These backup support features can also be incorporated onto accessory devices, such as the guide catheter.
- the deployment device 630 is part of a guiding catheter assembly, including a delivery catheter 670 coaxially oriented and slideably engaged over a distal catheter 675 , which may be coaxially oriented and slideably engaged over a proximal catheter 680 .
- a needle assembly 605 is similarly coaxially oriented and slideably engaged within the distal catheter 675 .
- the distal tip of a guiding catheter is first positioned within the right atrium according to a transeptal access method, which is further described in more detail as follows.
- the right venous system is first accessed using the “Seldinger” technique, wherein a peripheral vein (such as a femoral vein) is punctured with a needle, the puncture wound is dilated with a dilator to a size sufficient to accommodate an introducer sheath, and an introducer sheath with at least one hemostatic valve is seated within the dilated puncture wound while maintaining relative hemostasis.
- the guiding catheter or sheath is introduced through the hemostatic valve of the introducer sheath and is advanced along the peripheral vein, into the region of the vena cavae, and into the right atrium.
- the distal tip of the guiding catheter is positioned against the septum secundum 110 in the intra-atrial septal wall.
- the needle 605 is then advanced distally through the distal device catheter 675 until the needle 605 , and distal device catheter 675 puncture through both the septum secundum 110 and septum primum 105 into the left atrium.
- the configuration of the deployment device 630 including the needle 605 and distal device catheter 675 , puncturing through the septum secundum 110 and septum primum 105 is shown in FIG. 11 .
- FIG. 12 is a section view of the closure device and proximal device catheter 680 loaded into the distal end of the distal device catheter 675 .
- the anchor 620 is deployed into the left atrium by holding delivery catheter 670 and distal device catheter 675 steady, and distally advancing the proximal device catheter 680 and plunger 615 .
- the proximal device catheter 680 pushes against the back portion of anchor 620 until anchor 620 is advanced from the distal end of the distal device catheter 675 .
- the movement of anchor 620 necessarily translates, through closure line 625 , to movement of anchor 621 .
- FIG. 13 illustrates the anchor 620 deployed from the needle 605 by the plunger 615 according to one embodiment of the present invention.
- FIG. 14 illustrated the partial retraction of the proximal and distal device catheters 680 , 675 and seating of the distal anchor 620 according to one embodiment of the present invention.
- friction between the coaxially oriented members is such that retraction of the distal device catheter 675 will necessarily cause the simultaneous retraction of the proximal device catheter 680 and plunger 615 .
- FIG. 15 is a section view illustrating the plunger 615 deploying the proximal anchor 621 from the distal end of the proximal and distal device catheters 680 , 675 .
- anchor 621 may be slid toward anchor 620 along closure line 625 until sufficient relative proximation is achieved between septum primum 105 and septum secundum 110 .
- Any unwanted length of closure line 625 that remains unconstrained within the right atrium may be mechanically removed.
- Devices known in the art capable of removing the excess closure line 625 include catheter-based snare and cut devices. In addition to independent devices, a mechanical cut and removal mechanism may be integrated into the deployment device 630 .
- closure device will then be in position, with the anchor 621 opened against the septum secundum 110 , and the closure line 625 connecting the anchors 620 , 621 through the septum primum 105 and septum secundum 110 , holding the septum primum 105 in place.
- FIG. 16 illustrates the closure device 600 in the fully deployed position.
- FIGS. 17 though 22 are section views illustrating the method steps for deploying the closure device 600 through the septum primum 105 only, and achieve proximation between the septum primum 105 and septum secundum 110 , according to one embodiment of the present invention.
- the distal tip of the guiding catheter is positioned against the septum primum 105 in the intra-atrial septal wall.
- the needle 605 is then advanced distally through the distal device catheter 675 until the needle 605 punctures through the septum primum 105 into the left atrium.
- the configuration of the deployment device 630 including the needle 605 and distal device catheter 675 puncturing through the septum secundum 110 and septum primum 105 is shown in FIG. 17 .
- FIG. 18 is a section view of the closure device and proximal device catheter 680 loaded into the distal end of the distal device catheter 675 .
- the anchor 620 is deployed into the left atrium by holding delivery catheter 670 and distal device catheter 675 steady, and distally advancing the proximal device catheter 680 and plunger 615 .
- the proximal device catheter 680 pushes against the back portion of anchor 620 until anchor 620 is advanced from the distal end of the distal device catheter 675 .
- the movement of anchor 620 necessarily translates, through closure line 625 , to movement of anchor 621 .
- FIG. 19 illustrates the anchor 620 deployed from the needle 605 by the plunger 615 according to one embodiment of the present invention.
- FIG. 20 illustrated the partial retraction of the proximal and distal device catheters 680 , 675 and seating of the distal anchor 620 according to one embodiment of the present invention.
- friction between the coaxially oriented members is such that retraction of the distal device catheter 675 will necessarily cause the simultaneous retraction of the proximal device catheter 680 and plunger 615 .
- FIG. 21 is a section view illustrating the plunger 615 deploying the proximal anchor 621 from the distal end of the proximal and distal device catheters 680 , 675 .
- proximal anchor 621 is of sufficient size and shape to seat against the septum primum 105 and septum secundum 110 . If necessary, anchor 621 may be slid toward anchor 620 along closure line 625 until sufficient relative proximation is achieved between septum primum 105 and septum secundum 110 .
- Any unwanted length of closure line 625 that remains unconstrained within the right atrium may be mechanically removed.
- Devices known in the art capable of removing the excess closure line 625 include catheter-based snare and cut devices.
- a mechanical cut and removal mechanism may be integrated into the deployment device 630 .
- closure device will then be in position, with the anchor 621 opened against the septum secundum 110 , and the closure line 625 connecting the anchors 620 , 621 through the septum primum 105 and septum secundum 110 , holding the septum primum 105 in place.
- FIG. 22 illustrates the closure device 600 in the fully deployed position.
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Surgical Instruments (AREA)
Abstract
The present invention relates to devices for closing a passageway in a body, for example a patent foramen ovale (PFO) in a heart, and related methods of using such closure devices for closing the passageway. The method includes introducing a mechanical closure device into an atrium of the heart and transeptally deploying the closure device across the interatrial septum to provide proximation of the septum secundum and septum primum.
Description
- This application claims the benefit of U.S. Provisional Applications, Ser. No. 60/713,388, filed Sep. 1, 2005, which is incorporated by reference herein.
- This invention relates to devices for closing a passageway in a body, for example a patent foramen ovale (PFO) in a heart, and related methods of using such closure devices for closing the passageway.
- Patent foramen ovale (PFO) is an anatomical interatrial communication with potential for right-to-left shunting of blood. Patent foramen ovale is a flap-like opening between the atrial septa primum and secundum at the location of the fossa ovalis that persists after age one year. In utero, the foramen ovale serves as a physiologic conduit for right-to-left shunting of blood in the fetal heart. After birth, with the establishment of pulmonary circulation, the increased left atrial blood flow and pressure presses the septum primum (SP) against the walls of the septum secundum (SS), covering the foramen ovale and resulting in functional closure of the foramen ovale. This closure is usually followed by anatomical closure of the foramen ovale due to fusion of the septum primum (SP) to the septum secundum (SS).
- Where anatomical closure of the foramen ovale does not occur, a patent foramen ovale (PFO) is created. A patent foramen ovale is a persistent, usually flap-like opening between the atrial septum primum (SP) and septum secundum (SS) of a heart. A patent foramen ovale results when either partial or no fusion of the septum primum (SP) to the septum secundum (SS) occurs. In the case of partial fusion or no fusion, a persistent passageway (PFO track) exists between the septum primum (SP) and septum secundum (SS). This opening or passageway is typically parallel to the plane of the septum primum, and has a mouth that is generally oval in shape. Normally the opening is relatively long, but quite narrow. The opening may be held closed due to the mean pressure in the left atrium (LA) being typically higher than in the right atrium (RA). In this manner, the septum primum acts like a one-way valve, preventing fluid communication between the right and left atria through the PFO track. However, at times, the pressure may temporarily be higher in the right atrium, causing the PFO track to open up and allow some fluid to pass from the right atrium to the left atrium. Although the PFO track is often held closed, the endothelialized surfaces of the tissues forming the PFO track prevent the tissues from healing together and permanently closing the PFO track.
- Studies have shown that a relatively large percentage of adults have a patent foramen ovale (PFO). It is believed that embolism via a PFO may be a cause of a significant number of ischemic strokes, particularly in relatively young patients. It has been estimated that in 50% of cryptogenic strokes, a PFO is present. Blood clots that form in the venous circulation (e.g., the legs) can embolize, and may enter the arterial circulation via the PFO, subsequently entering the cerebral circulation, resulting in an embolic stroke. Blood clots may also form in the vicinity of the PFO, and embolize into the arterial circulation and into the cerebral circulation. Patients suffering a cryptogenic stroke or a transient ischemic attack (TIA) in the presence of a PFO often are considered for medical therapy to reduce the risk of a recurrent embolic event.
- Pharmacological therapy often includes oral anticoagulants or antiplatelet agents. These therapies may lead to certain side effects, including hemorrhage. If pharmacologic therapy is unsuitable, open heart surgery may be employed to close a PFO with stitches, for example. Like other open surgical treatments, this surgery is highly invasive, risky, requires general anesthesia, and may result in lengthy recuperation.
- Nonsurgical closure of a PFO is possible with umbrella-like devices developed for percutaneous closure of atrial septal defects (ASD) (a condition where there is not a well-developed septum primum (SP)). Many of these conventional devices used for ASD, however, are technically complex, bulky, and difficult to deploy in a precise location. In addition, such devices may be difficult or impossible to retrieve and/or reposition should initial positioning not be satisfactory. Moreover, these devices are specially designed for ASD and therefore may not be suitable to close and seal a PFO, particularly because the septum primum (SP) overlaps the septum secundum (SS).
- The present invention relates to a method of deploying a mechanical closure device through the septum of a heart to facilitate closing of a patent foramen ovale. The method comprises the steps of accessing a first atrium of the heart with a deployment device carrying the mechanical closure device. The mechanical closure device includes a proximal and distal anchor with a closure line attached there between. The deployment device is then advanced distally until the deployment device penetrates through the interatrial septum into the second atrium. A mechanical closure device is then introduced into the second atrium of the heart. The closure device is then transeptally deployed across the septum secundum and/or septum primum to provide proximation between the septum secundum and septum primum.
- In another embodiment of the present invention, the method comprises the steps of accessing a first atrium of the heart with a deployment device carrying the mechanical closure device. The mechanical closure device includes a proximal and distal anchor with a closure line attached there between. The deployment device is then advanced distally until the deployment device penetrates through at least one appendage of the interatrial septum into the second atrium. A mechanical closure device is then introduced into the second atrium of the heart. The closure device is then transeptally deployed across the penetrated interatrial septum to provide proximation between the septum secundum and septum primum.
-
FIG. 1 is a short axis view of the heart at the level of the right atrium (RA) and the left atrium (LA), in a plane generally parallel to the atrio-ventricular groove, and at the level of the aortic valve, showing a PFO track. -
FIG. 2 is a cross-sectional view of the PFO track ofFIG. 1 in a closed configuration. -
FIG. 3 is a close-up section view illustrating the PFO track held in the closed position by left atrial pressure. -
FIG. 4A is a cross-sectional view of the PFO track ofFIG. 2 in an open configuration. -
FIG. 4B is a close-up section view illustrating the PFO track in an open configuration. -
FIG. 5A is a cross-sectional view illustrating the PFO tract ofFIG. 1 . -
FIG. 5B is a section view taken along line A-A inFIG. 4B . -
FIG. 5C is a section view taken along line A-A inFIG. 3 . -
FIG. 5D is a close-up section view of the PFO track, showing the tunnel formed by the tissue extension. -
FIG. 6A is a perspective view illustrating the relationship between the components comprising the closure device and deployment device according to one aspect of the present invention. -
FIG. 6B illustrates the closure device deployed through the septum secundum and septum primum along the PFO track to close the PFO according to one embodiment of the present invention. -
FIG. 7A is a perspective view of the anchor structure in the cut pre-expanded form according to one embodiment of the present invention. -
FIG. 7B is a perspective view of the expanded anchor according to one embodiment of the present invention. -
FIG. 7C is a perspective view of the anchor under tensioning of the closure line according to one embodiment of the present invention. -
FIG. 8A illustrates substantial closure of the PFO track with the closure device deployed through the septum secundum and septum primum along the PFO track to close the PFO according to one embodiment of the present invention. -
FIG. 8B illustrates substantial closure of the PFO tract with a single penetration through both the septum primum and septum secundum according to one embodiment of the present invention. -
FIG. 8C illustrates substantial closure of the PFO track with a single penetration through the septum primum according to one embodiment of the present invention. -
FIG. 8D illustrates substantial closure of the PFO, where an ASA is present, with a single penetration only through the septum primum according to one embodiment of the present invention. -
FIG. 8E illustrates substantial closure of the PFO with a single penetration through the septum primum according to one embodiment of the present invention. -
FIG. 8F illustrates the deployment of the closure device through a single penetration in the septum secundum according to one embodiment of the present invention. -
FIG. 9A is a section view of the heart illustrating a deployment device having backup support in the form of an axially asymmetric spline according to one embodiment of the present invention. -
FIG. 9B is a section view of the heart illustrating a deployment device having backup support in the form of an axially asymmetric balloon according to one embodiment of the present invention. -
FIG. 9C is a section view of the heart illustrating a deployment device with a shape along the distal end to provide backup support, according to one embodiment of the present invention. -
FIG. 10 is a perspective view illustrating exemplary sensors, such as a hydraulic pressure port sensor and electrical pressure transducer. -
FIG. 11 is a perspective view showing the relationship between components comprising the deployment device and closure device after the needle punctures through the septum secundum and septum primum into the left atrium, according to one embodiment of the present invention. -
FIG. 12 is a perspective view showing the relationship between components comprising the deployment device and closure device after the needle retracted and the proximal device catheter, closure device and plunger are back-loaded into the distal end of the distal device catheter. -
FIG. 13 is a perspective view showing the relationship between components comprising the deployment device and closure device after the proximal device catheter is advanced along the distal device catheter and deploys thedistal anchor 620, according to one embodiment of the present invention. -
FIG. 14 is a perspective view showing the relationship between components comprising the deployment device and closure device after the proximal and distal device catheters are partially retracted back through the delivery catheter, according to one embodiment of the present invention. -
FIG. 15 is a perspective view showing the relationship between components comprising the deployment device and closure device after the delivery catheter, proximal device catheter and distal device catheter are partially retracted and the plunger advanced to deploy the proximal anchor, according to one embodiment of the present invention. -
FIG. 16 is a perspective view showing the relationship between components comprising the deployment device and closure device after the closure device is fully deployed, according to one embodiment of the present invention. -
FIG. 17 is a perspective view showing the relationship between components comprising the deployment device and closure device after the needle punctures through the septum primum into the left atrium, according to one embodiment of the present invention. -
FIG. 18 is a perspective view showing the relationship between components comprising the deployment device and closure device after the needle retracted and the proximal device catheter, closure device and plunger are back-loaded into the distal end of the distal device catheter. -
FIG. 19 is a perspective view showing the relationship between components comprising the deployment device and closure device after the proximal device catheter is advanced along the distal device catheter and deploys thedistal anchor 620, according to one embodiment of the present invention. -
FIG. 20 is a perspective view showing the relationship between components comprising the deployment device and closure device after the proximal and distal device catheters are partially retracted back through the delivery catheter, according to one embodiment of the present invention. -
FIG. 21 is a perspective view showing the relationship between components comprising the deployment device and closure device after the delivery catheter, proximal device catheter and distal device catheter are partially retracted and the plunger advanced to deploy the proximal anchor, according to one embodiment of the present invention. -
FIG. 22 is a perspective view showing the relationship between components comprising the deployment device and closure device after the closure device is fully deployed, according to one embodiment of the present invention. - The various figures show embodiments of the patent foramen ovale (PFO) closure device and methods of using the device to close a PFO. The device and related methods are described herein in connection with mechanically closing a PFO. These devices, however, also are suitable for closing other openings or passageways, including other such openings in the heart, for example atrial septal defects, ventricular septal defects, and patent ducts arterioses, as well as openings or passageways in other portions of a body such as an arteriovenous fistula. The invention therefore is not limited to use of the inventive closure devices to close PFO's.
- A human heart has four chambers. The upper chambers are called the left and right atria, and the lower chambers are called the left and right ventricles. A wall of muscle called the septum separates the left and right atria and the left and right ventricles. That portion of the septum that separates the two upper chambers (the right and left atria) of the heart is termed the atrial (or interatrial) septum while the portion of the septum that lies between the two lower chambers (the right and left ventricles) of the heart is called the ventricular (or interventricular) septum.
-
FIG. 1 illustrates a short-axis view of theheart 100 at the level of the right atrium (RA) and left atrium (LA), in a plane generally parallel to the atrio-ventricular groove, and at the level of the aortic valve. This view is looking from caudal to cranial.FIG. 1 also shows the septum primum (SP) 105, a flap-like structure, which normally covers theforamen ovale 115, an opening in the septum secundum (SS) 110 of theheart 100. In utero, theforamen ovale 115 serves as a physiologic conduit for right-to-left shunting of blood in the fetal heart. After birth, with the establishment of pulmonary circulation, the increased left atrial blood flow and pressure presses the septum primum (SP) 105 against the walls of the septum secundum (SS) 110, covering theforamen ovale 115 and resulting in functional closure of theforamen ovale 115. This closure is usually followed by anatomical closure of theforamen ovale 115 due to fusion of the septum primum (SP) 105 to the septum secundum (SS) 110. - The PFO results when either partial or no fusion of the septum primum 105 to the
septum secundum 110 occurs. When this condition exists, a passageway (PFO track) 120 between the septum primum 105 andseptum secundum 110 may allow communication of blood between the atria. ThisPFO track 120 is typically parallel to the plane of theseptum primum 105, and has an opening that is generally oval in shape.FIG. 2 illustrates the opening of thePFO track 120 as viewed from an end of the track. Normally the opening is relatively tall, but quite narrow. The opening may be held closed by the mean pressure in the left atrium, which is typically higher than the right atrium.FIG. 3 is a close-up section view of thePFO track 120 held in the closed position by left atrial pressure. In this position, the septum primum 105 acts like a one-way valve, preventing fluid communication between the right and left atria through thePFO track 120. Occasionally, the pressure in the right atrium may temporarily be higher than the left atrium. When this condition occurs, thePFO track 120 opens and allow some fluid to pass from the right atrium to the left atrium, as indicated inFIGS. 4A and 4B . In particular,FIG. 4A is a cross-sectional view showing the PFO track ofFIG. 2 in an open configuration. Similarly,FIG. 4B is a close-up section view illustrating the PFO track in an open configuration. - Although the
PFO track 120 is often held closed, the endothelialized surfaces of the tissues forming thePFO track 120 prevent the tissue from healing together and permanently closing thePFO track 120. As can be seen inFIGS. 5A-5C , (a view from line “C-C” ofFIG. 1 ), theseptum primum 105 is firmly attached to theseptum secundum 110 around most of the perimeter of theFossa Ovalis 115, but has an opening along one side. The septum primum 105 is often connected, as shown, by two or more extensions of tissue along the sides of thePFO track 120 forming a tunnel.FIG. 5D is a magnified section view of thePFO track 120, showing the tunnel formed by the tissue extensions. Typically, the tunnel length in an adult human can range between 2 and 13 mm. - The present invention relates to a system and method for closing a passageway in a body. In a particular embodiment, the device is used to close the Patent Foramen Ovale in a human heart. One of ordinary skill in the art would understand that similar embodiments could be used to close other passageways and openings in the body without departing from the general intent or teachings of the present invention.
-
FIGS. 6A and 6B illustrate a device used to close the PFO according to one embodiment of the present invention. Thedevice 600 comprises aflexible closure line 625 coupled to twoexpandable anchors Anchor 620 is coupled to distal end of theclosure line 625, whileanchor 621 is coupled to the proximal end of theflexible closure line 625.Anchor 621 is capable of sliding alongclosure line 625 and locking in desired location to cinch or take-up slack inclosure line 625 length, bringing the proximal anddistal anchors septum secundum 110 and the septum primum 105 in close proximation. - It should be noted that the
septum secundum 110 and the septum primum 105 do not have to be tightly touching to effect proper closure of the PFO. Instead, theseptum secundum 110 and theseptum primum 105 must just be brought close enough to minimize flow from atria to atria (typically flow from left atria to right atria). - The locking mechanism incorporated into
anchor 621 may be a device capable of allowing theclosure line 625 to slide throughanchor 621 in one direction, and prevent sliding movement in the opposite direction. Examples of functionally similar commercial locking mechanisms include the DePuy Mitek RAPIDLOC™ device; zip ties; and similar linear locking devices known in the art. - Alternatively, the
anchor 621 may be fixed to theclosure line 625 at a predetermined distance fromanchor 620. This may particularly be the case when theclosure line 625 has an elastic or recoil ability and is capable of exerting tension when deployed, pulling theanchors septum secundum 110. In still a further embodiment of the invention, aclosure device 600 may include anelastic closure line 625 and aslideable anchor 621. In this embodiment, theanchor 621 is capable of allowing theflexible closure line 625 to slide through theanchor 621 in one direction, and prevent sliding movement in the opposite direction, while theclosure line 625 exerts tension between the twoanchors anchors inelastic closure line 625. - The
closure line 625 may be any biocompatible filament known in the art that is capable of securing the septum primum 105 to theseptum secundum 110. In a preferred embodiment theclosure line 625 is a surgical suture, such as a multifilament non-biodegradable suture, or a forced entangled fiber filament. Alternatively, theclosure line 625 may be made from an elastic material capable of exerting tension when stretched. In yet another alternative embodiment, theclosure line 625 may be geometrically configured to exhibit structurally elastic behavior. In another alternative embodiment, theclosure line 625 may be made from an anelastic material such as elastomeric polymers that are capable of exerting tension when stretched. In yet another alternative embodiment, theclosure line 625 may be made from a super elastic material such as a nickel titanium alloy. - The
anchors anchors - Structurally deformable materials are materials that can elastically or plastically deform without compromising their integrity. Geometric structures, such as
anchors - Geometric structures made from structurally deformable materials are typically self expanding or mechanically expandable. In a preferred embodiment, the
anchors anchors - Some structurally deformable materials may also be mechanically expandable. Geometric structures can be mechanically expanded by introduction of an external force, through, for example, a mechanical expansion means. Mechanical expansion means are well known in the art and include balloon or cage expansion devices.
- Once an external mechanical force is introduced to the geometric structure, the structure plastically deforms to its desired final configuration.
- The
anchors anchor septum secundum 110, as the case may be, once deployed. - In a preferred embodiment, the
anchors Nitinol hypotube 700 by methods known in the art.FIG. 7A is a perspective view of theanchor 620 in the cut pre-expanded form. - The
anchor 620 is then formed into a desired expanded configuration and annealed to assume a stress-free (relaxed) state. In one embodiment of the invention, theanchor legs 710. A perspective view of the expandedbasket anchor 620 according to one embodiment of the present invention is illustrated inFIG. 7B . - Once the
closure device 600 is deployed, the basket shapedanchors closure line 625, into a flattened “flower petal” shape as illustrated inFIG. 7C . In this state, theanchors anchors closure line 625 in tension. -
FIG. 8A illustrates theclosure device 600 having flower petal shapedanchors proximal anchor 621 inFIG. 8A also includes alocking mechanism 622 integrated therein. - This anchor design should not be considered a limiting feature of the invention, as other shapes and configurations of
anchors anchors needles 605, 610 in the constrained state. Once deployed, the long axis of theanchor needle 605, 610 longitudinal axis, effectively anchoring theclosure line 625 in place. - Although
FIG. 8A illustrates theclosure device 600 deployed through theseptum secundum 110 and septum primum 105 along thePFO track 120, it should be understood that theclosure device 600 may be deployed through other locations to achieve the same results. In addition, each of theFIGS. 8A through 8F illustrate theanchors closure line 625 in a particular orientation. It should be understood that position of theanchor structures -
FIGS. 8B through 8F illustrate theclosure device 600 deployed at various locations across the septum primum 105 and/orseptum secundum 110. Although the penetration through the septum primum 105 and/orseptum secundum 110 are shown at different locations, common to each of the illustrated deployments is the location of thedistal anchor 620 and theproximal anchor 621 in the left and right atrial chambers respectively. -
FIG. 8B illustrates substantial closure of thePFO tract 120 with a single penetration through both the septum primum 105 andseptum secundum 110. - It should be noted that both the septum primum 105 and
septum secundum 110 do not have to be penetrated to maintain close enough proximity between the septal tissues to achieve proper closure of the PFO.FIG. 8C illustrates substantial closure of the PFO with a single penetration only through theseptum primum 105. In the illustrated embodiment, there is significant overlap between the septum primum 105 andseptum secundum 110 creating a fairlylong track 120. The distal andproximal anchors septum secundum 110 to facilitate closing of thePFO track 120 when theclosure line 625 is tensioned. - The
PFO closure device 600 can be used to facilitate closing thePFO track 120 when other defects in the septal wall are present. For example, thePFO closure device 600 may be used when an atrial septal aneurysm (ASA) 805 is present. An ASA is characterized as a saccular deformity, generally at the level of the fossa ovale, which protrudes to the right or left atrium, or both.FIG. 8D illustrates substantial closure of the PFO, where an ASA is present, with a single penetration only through theseptum primum 105. However, the distal and proximal anchors, 620 and 621 respectively, are sized to contact both the septum primum 105 andseptum secundum 110 to facilitate closing of thePFO track 120. - The single penetration method may also be employed where there is minimal overlap between the septum primum 105 and
septum secundum 110. This so called “short tunnel” PFO may not be readily closed with prior art “intra-tunnel methods.FIG. 8E illustrates substantial closure of the PFO with a single penetration through theseptum primum 105. - Similar to the single penetration method illustrated in
FIGS. 8A through 8E , theclosure device 600 may be deployed using a single penetration through theseptum secundum 110 as illustrated inFIG. 8F . - The present invention utilizes a removable deployment device to introduce the
mechanical closure device 600 into the atrium of the heart, preferably through a minimally invasive, transluminal procedure. - Minimally invasive heart surgery refers to several approaches for performing heart operations that are less difficult and risky than conventional open-heart surgery. These approaches restore healthy blood flow to the heart without having to stop the heart and put the patient on a heart-lung machine during surgery. Minimally invasive procedures are carried out by entering the body through the skin, a body cavity or anatomical opening, but with the smallest damage possible to these structures. This results in less operative trauma for the patient. It also less expensive, reduces hospitalization time, causes less pain and scarring, and reduces the incidence of complications related to the surgical trauma, speeding the recovery.
- One example of a minimally invasive procedure for performing heart surgery is a trans-thoracic laparoscopic (endoscopic) procedure. The part of the mammalian body that is situated between the neck and the abdomen and supported by the ribs, costal cartilages, and sternum is known as the thorax. This division of the body cavity lies above the diaphragm, is bounded peripherally by the wall of the chest, and contains the heart and lungs. Once into the thorax, the surgeon can gain access to the atrium of the heart through an atriotomy, a surgical incision of an atrium of the heart. For example, if the surgeon wishes to gain access to the right atrium they will perform an atriotomy in the right atrial appendage.
- The primary advantage of a trans-thoracic laparosopic procedure is that there is no need to make a large incision. Instead, the surgeon operates through 3 or 4 tiny openings about the size of buttonholes, while viewing the patient's internal organs on a monitor. There is no large incision to heal, so patients have less pain and recover sooner. Rather than a 6- to 9-inch incision, the laparoscopic technique utilized only 4 tiny openings—all less than ½ inch in diameter.
- Another minimally invasive technique for gaining access to the heart and deploying the closure device is a percutaneous transluminal procedure. Percutaneous surgical techniques pertain to any medical procedure where access to inner organs or other tissue is done via needle-puncture of the skin, rather than by using an “open” approach where inner organs or tissue are exposed (typically with the use of scalpel). The percutaneous approach is commonly used in vascular procedures, where access to heart is gained through the venous or arterial systems. This involves a needle catheter getting access to a blood vessel, followed by the introduction of a wire through the lumen of the needle. It is over this wire that other catheters can be placed into the blood vessel. This technique is known as the modified Seldinger technique. The
PFO closure device 600 may also be deployed via percutaneous methods by steerable catheters or guidewires. - In the Seldinger technique a peripheral vein (such as a femoral vein) is punctured with a needle, the puncture wound is dilated with a dilator to a size sufficient to accommodate an introducer sheath, and an introducer sheath with at least one hemostatic valve is seated within the dilated puncture wound while maintaining relative hemostasis.
- Penetration of the interatrial septum requires piecing the septal wall. In a preferred embodiment this penetration is accomplished by using a needle, trocar or similar device to accomplish non-core cutting of the interatrial septum. In one embodiment of the invention, the non-core cutting device is a tubular needle-like structure, however other configurations and shaped structures may be used as would be understood by one skilled in the art. The needle tube is a substantially rigid structure capable of penetrating the
septum secundum 110 and septum primum 105 along thePFO track 120. The needle is preferably sized to be 13 French or smaller, most preferably 10 French or smaller, and made from a biocompatible material, such as, for example surgical stainless steel, Nitinol, or Cobalt-Chromium alloys. It should be understood that these materials are not meant to limit the scope of the invention. Any biocompatible material capable of being sharpened and holding a sharp edge, and having sufficient strength to facilitate penetration through theseptum secundum 110 and/or septum primum 105, may be suitable. The needle is constructed with a tapered distal end, as is known in the art. In a preferred embodiment, the geometric configuration of the tapered distal end is optimized to minimize induced tissue trauma at the site of penetration. In addition, the needle is of sufficient body length to penetrate both theseptum secundum 110 andseptum primum 105, while still maintaining the needed size and axial flexibility to navigate the tortuous vessel anatomy when being delivered to the heart percutaneously. - In another embodiment of the invention, penetrating the interatrial septum may be accomplished by drilling through the septum.
- With the introducer sheath in place, the guiding catheter or
delivery member 630 of the closure device is introduced through the hemostatic valve of the introducer sheath and is advanced along the peripheral vein, into the region of the vena cavae, and into the right atrium. - In one embodiment of the invention, the distal tip of the
delivery device 630 is positioned against the interatrial septal wall. In the case of a septum having a PFO, the interatrial septal wall may be the septum primum 105 and/orseptum secundum 110, as the case may be. A needle or trocar associated with thedelivery device 630 is then advanced distally until it punctures the septum primum 105 and orseptum secundum 110. A separate dilator may also be advanced with the needle through the septum primum 105 and/orseptum secundum 110 to prepare an access port through the septum primum 105 and/orseptum secundum 110 for seating thedelivery device 630. Thedelivery device 630 traverses across the septum and is seated in the left atrium, thereby providing access forclosure devices 600 through its own inner lumen and into the left atrium. - It is however further contemplated that other left atrial access methods may be suitable substitutes for using the
delivery device 630 andclosure device 600 of the present invention. In one alternative variation not shown, a “retrograde” approach may be used, wherein thedelivery device 630 is advanced into the left atrium from the arterial system. In this variation, the Seldinger technique is employed to gain vascular access into the arterial system, rather than the venous, for example, at a femoral artery. Thedelivery device 630 is advanced retrogradedly through the aorta, around the aortic arch, into the ventricle, and then into the left atrium through the mitral valve. - Once in the desired atrium of the heart the
closure device 600 is deployed transeptally from one atria to the other. For the purpose of this invention, transeptally is defined as deployment from one atria to the other through the septum (septum primum 105 and/or septum secundum 110), as apposed to intra-atrial access through the PFO tract 120 (tunnel). In the case of a heart having a patent foramen ovale, transeptal penetration may be through the septum primum (SP) 105 and/or septum secundum (SS) 110, or visa versa, whichever the case may be. Preferably, the angle of transeptal penetration is between 45 and 135 degrees to the surface of the septum, but is most preferably orthogonal to the surface of the septum. - By way of example, in one embodiment of the present invention using right atrial access, the right atrium is first accessed by the delivery device 630 (and closure device 600). The
closure device 600 may then be deployed by penetrating the interatrial septum (septum primum 105 and/or septum secundum 110) from the right atrial chamber to the left atrial chamber in the heart, and deploying thedistal anchor 620 associated with theclosure device 600 into the left atrial chamber. After successful deployment of thedistal anchor 620, thedelivery device 630 may be partially withdrawn from the left atrial chamber to the right atrial chamber, leaving thedistal anchor 620 in place. Theproximal anchor 621 associated with theclosure device 600 can then be deployed into the right atrial chamber. This substantially linear atrial deployment method is shown inFIGS. 8A through 8F . - Similar procedures are employed when left an atrial access technique is used. For example, in one embodiment of the present invention using left atrial access, the left atrium is first accessed by the delivery device 630 (and closure device 600). The
closure device 600 may then be deployed by penetrating the interatrial septum (septum primum 105 and/or septum secundum 110) from the left atrial chamber to the right atrial chamber in the heart, and deploying thedistal anchor 620 associated with the closure device into the first atrium. After successful deployment of thedistal anchor 620, thedelivery device 630 may be partially withdrawn from the right atrial chamber to the left atrial chamber, leaving thedistal anchor 620 in place. Theproximal anchor 621 associated with the closure device can then be deployed into the left atrial chamber. - Once the proximal anchor is deployed, the closure device may be cinched to bring the proximal and distal anchors closer together. This results in the
septum secundum 110 and theseptum primum 105 being brought in close proximation to facilitate closure of the Patent Foramen Ovale. It should be noted that theseptum secundum 110 and the septum primum 105 do not have to be tightly touching to effect proper closure of the PFO. Instead, theseptum secundum 110 and theseptum primum 105 must just be brought close enough to minimize flow from atria to atria (typically flow from right atria to left atria). - To achieve and maintain the proximity between the
septum secundum 110 and theseptum primum 105, it may be necessary to adjust the proximal anchor by uni-axially cinching or sliding theproximal anchor 620 alongclosure line 625. In one embodiment of the invention, cinching comprises uni-axially adjusting the proximal anchor relative to a closure line associated with the closure device. In another embodiment of the invention, cinching comprises incrementally adjusting the proximal anchor relative to a closure line associated with the closure device. - Once the closure device is cinched in place the method may further comprise assessing the degree of proximation between the
septum secundum 110 and theseptum primum 105. - In one embodiment of the invention, the clinician may visually assess the proximation though an endoscopic or fluoroscopic procedure. In addition, other methods may be used to measure the proximation between the
septum secundum 110 and theseptum primum 105, such as through pressure observation or infrared imaging. - After proper cinching, any unwanted length of
closure line 625 that remains unconstrained within the right atrium may be mechanically removed. Devices known in the art capable of removing theexcess closure line 625 include catheter-based snare and cut devices. In addition to independent devices, a mechanical cut and removal mechanism may be integrated into the deployment device. - The closure device will then be in position, with the
anchors septum secundum 110, and theclosure line 625 connecting theanchors septum secundum 110, thus holding the septum primum 105 in place. - Another embodiment of the invention may include a location monitoring system to facilitate placement of the
deployment device 630. In particular, the location monitoring device will assist in determining whether the clinician is in the correct chamber of the heart. - In a preferred embodiment, the location monitoring system includes the ability to measure localized pressure relative to the distal end of the
deployment device 630. The pressure measurement read by the location monitoring system may be achieved by electronic, mechanical and/or physical means, such as a solid-state pressure transducer, spring loaded diaphragm, hydraulic pressure port, and/or communicating manometer. These and other pressure measurement techniques would be known by one of skill in the art.FIG. 10 is a perspective view illustrating exemplary sensors, such as ahydraulic pressure port 655 orelectrical pressure transducer 660. - By way of example it is well known that pressures vary in different locations within the cardiovascular system. Specifically, gage pressure in the right and left atrium are know to range from approximately 1-6 mmHg to 10 mmHg respectfully. Similarly, gage pressure within the ascending aorta ranges from approximately 120 to 160 mmHg during systole.
- Before deployment, the clinician will first monitor pressure within the right atrium. This reading should indicate a pressure of 1-6 mmHg. The distal end of the
outer needle 605 will be inserted through the septal wall (septum primum 105 and/or septum secundum 110) and into the left atrium. The monitored pressure should change to approximately 10 mmHg. A much higher reading, such as in the range of approximately 120 to 160 mmHg, indicates puncture of the aorta. The clinician will then have to retract theouter needle 605 and reposition thedelivery device 630 for re-entry. Similarly, once in the left atrium the inner needle 610 is advanced back into the right atrium. The clinician should observe a pressure change from 10 mmHg to 1-6 mmHg. - For delivery to the heart, the deployment device 630 (and thus the closure device 600) is used in conjunction with an accessory device (not shown) known in the art. In a preferred embodiment, the accessory device may be a guiding catheter that tracks over a guidewire, and is steered through the vasculature into the right atrium.
- In another embodiment, the accessory device and
deployment device 630 may be formed as an integrated component, capable of being steered through the vasculature. - To facilitate deployment of the
closure device 600, thedeployment device 630 may include features that provide backup support. This backup support may include, for example: an axially asymmetric expansion member attached along anouter shaft 635, such as a balloon orself expanding cage 640; aspline 645; or imparting ashape 650 along the body of thedeployment device 630. Examples of these backup support features are illustrated in FiguresFIGS. 9A through 9C , respectively. It should be understood that theouter shaft 635 may be part of the guiding catheter, or integrated into thedeployment device 630. These and other such backup support devices would be understood by one of skill in the art. These backup support features can also be incorporated onto accessory devices, such as the guide catheter. - Still other embodiments utilizing known methods and apparatus to deliver the
deployment device 630 andclosure device 600 into the atrium ofheart 100 would be obvious to one of skill in the art. - In one embodiment of the invention, the
deployment device 630 is part of a guiding catheter assembly, including adelivery catheter 670 coaxially oriented and slideably engaged over adistal catheter 675, which may be coaxially oriented and slideably engaged over aproximal catheter 680. Aneedle assembly 605 is similarly coaxially oriented and slideably engaged within thedistal catheter 675. - The distal tip of a guiding catheter is first positioned within the right atrium according to a transeptal access method, which is further described in more detail as follows. The right venous system is first accessed using the “Seldinger” technique, wherein a peripheral vein (such as a femoral vein) is punctured with a needle, the puncture wound is dilated with a dilator to a size sufficient to accommodate an introducer sheath, and an introducer sheath with at least one hemostatic valve is seated within the dilated puncture wound while maintaining relative hemostasis. With the introducer sheath in place, the guiding catheter or sheath is introduced through the hemostatic valve of the introducer sheath and is advanced along the peripheral vein, into the region of the vena cavae, and into the right atrium.
- Once in the right atrium, the distal tip of the guiding catheter is positioned against the
septum secundum 110 in the intra-atrial septal wall. Theneedle 605 is then advanced distally through thedistal device catheter 675 until theneedle 605, anddistal device catheter 675 puncture through both theseptum secundum 110 and septum primum 105 into the left atrium. The configuration of thedeployment device 630, including theneedle 605 anddistal device catheter 675, puncturing through theseptum secundum 110 andseptum primum 105 is shown inFIG. 11 . - After the
needle 605 has penetrated the septum primum 105 andseptum secundum 110 into the left atrium, theneedle 605 is retracted from the distal device catheter 675 (and thus the delivery catheter 670) and replaced with aproximal device catheter 680. Thedistal device catheter 675 remains in place. The proximal device catheter has theclosure device 600, including the proximal anddistal anchors closure line 625 loaded within its distal end. Aplunger 615 may also be coaxially disposed and slideably engaged within theproximal catheter 680 to assist in deploying theclosure device 600.FIG. 12 is a section view of the closure device andproximal device catheter 680 loaded into the distal end of thedistal device catheter 675. - The
anchor 620 is deployed into the left atrium by holdingdelivery catheter 670 anddistal device catheter 675 steady, and distally advancing theproximal device catheter 680 andplunger 615. During deployment, theproximal device catheter 680 pushes against the back portion ofanchor 620 untilanchor 620 is advanced from the distal end of thedistal device catheter 675. The movement ofanchor 620 necessarily translates, throughclosure line 625, to movement ofanchor 621. Asanchor 620 enters the right atrium the shape memory material properties allow theanchor 620 to assume it unconstrained shape.FIG. 13 illustrates theanchor 620 deployed from theneedle 605 by theplunger 615 according to one embodiment of the present invention. - Once the
distal anchor 620 is released from thedistal device catheter 675, the proximal anddistal device catheters delivery catheter 670. This retraction causes tension in theclosure line 625, and caused thedistal anchor 620 to seat against theseptum primum 105.FIG. 14 illustrated the partial retraction of the proximal anddistal device catheters distal anchor 620 according to one embodiment of the present invention. - It should be noted that in some embodiments, friction between the coaxially oriented members is such that retraction of the
distal device catheter 675 will necessarily cause the simultaneous retraction of theproximal device catheter 680 andplunger 615. - Once the proximal and
distal device catheters septum secundum 110 respectively, theplunder 615 may be used to deploy theanchor 621 to the fully unrestrained shape.FIG. 15 is a section view illustrating theplunger 615 deploying theproximal anchor 621 from the distal end of the proximal anddistal device catheters anchor 621 may be slid towardanchor 620 alongclosure line 625 until sufficient relative proximation is achieved between septum primum 105 andseptum secundum 110. Any unwanted length ofclosure line 625 that remains unconstrained within the right atrium may be mechanically removed. Devices known in the art capable of removing theexcess closure line 625 include catheter-based snare and cut devices. In addition to independent devices, a mechanical cut and removal mechanism may be integrated into thedeployment device 630. - The closure device will then be in position, with the
anchor 621 opened against theseptum secundum 110, and theclosure line 625 connecting theanchors septum secundum 110, holding the septum primum 105 in place. -
FIG. 16 illustrates theclosure device 600 in the fully deployed position. - As noted previously, certain anatomical features of the atrial chambers and atrial septum may allow adequate closure of the PFO to be made through only the
septum secundum 110 orseptum primum 105. FIGS. 17 though 22 are section views illustrating the method steps for deploying theclosure device 600 through theseptum primum 105 only, and achieve proximation between the septum primum 105 andseptum secundum 110, according to one embodiment of the present invention. - By way of example, once in the right atrium, the distal tip of the guiding catheter is positioned against the septum primum 105 in the intra-atrial septal wall. The
needle 605 is then advanced distally through thedistal device catheter 675 until theneedle 605 punctures through theseptum primum 105 into the left atrium. The configuration of thedeployment device 630, including theneedle 605 anddistal device catheter 675 puncturing through theseptum secundum 110 andseptum primum 105 is shown inFIG. 17 . - After the
needle 605 has penetrated theseptum primum 105 into the left atrium, theneedle 605 is retracted from the distal device catheter 675 (and thus the delivery catheter 670) and replaced with aproximal device catheter 680, which is back-loaded into the distal device catheter and advanced to its distal end. Thedistal device catheter 675 remains in place. The proximal device catheter has theclosure device 600, including the proximal anddistal anchors closure line 625 loaded within its distal end. Aplunger 615 may also be coaxially disposed and slideably engaged within theproximal catheter 680 to assist in deploying theclosure device 600.FIG. 18 is a section view of the closure device andproximal device catheter 680 loaded into the distal end of thedistal device catheter 675. - The
anchor 620 is deployed into the left atrium by holdingdelivery catheter 670 anddistal device catheter 675 steady, and distally advancing theproximal device catheter 680 andplunger 615. During deployment, theproximal device catheter 680 pushes against the back portion ofanchor 620 untilanchor 620 is advanced from the distal end of thedistal device catheter 675. The movement ofanchor 620 necessarily translates, throughclosure line 625, to movement ofanchor 621. Asanchor 620 enters the right atrium the shape memory material properties allow theanchor 620 to assume it unconstrained shape.FIG. 19 illustrates theanchor 620 deployed from theneedle 605 by theplunger 615 according to one embodiment of the present invention. - Once the
distal anchor 620 is released from thedistal device catheter 675, the proximal anddistal device catheters delivery catheter 670. This retraction causes tension in theclosure line 625, and caused thedistal anchor 620 to seat against theseptum primum 105.FIG. 20 illustrated the partial retraction of the proximal anddistal device catheters distal anchor 620 according to one embodiment of the present invention. - It should be noted that in some embodiments, friction between the coaxially oriented members is such that retraction of the
distal device catheter 675 will necessarily cause the simultaneous retraction of theproximal device catheter 680 andplunger 615. - Once the proximal and
distal device catheters septum primum 105, theplunder 615 may be used to deploy theanchor 621 to the fully unrestrained shape.FIG. 21 is a section view illustrating theplunger 615 deploying theproximal anchor 621 from the distal end of the proximal anddistal device catheters proximal anchor 621 is of sufficient size and shape to seat against the septum primum 105 andseptum secundum 110. If necessary,anchor 621 may be slid towardanchor 620 alongclosure line 625 until sufficient relative proximation is achieved between septum primum 105 andseptum secundum 110. Any unwanted length ofclosure line 625 that remains unconstrained within the right atrium may be mechanically removed. Devices known in the art capable of removing theexcess closure line 625 include catheter-based snare and cut devices. In addition to independent devices, a mechanical cut and removal mechanism may be integrated into thedeployment device 630. - The closure device will then be in position, with the
anchor 621 opened against theseptum secundum 110, and theclosure line 625 connecting theanchors septum secundum 110, holding the septum primum 105 in place. -
FIG. 22 illustrates theclosure device 600 in the fully deployed position. - These and other objects and advantages of this invention will become obvious to a person of ordinary skill in this art upon reading of the detailed description of this invention including the associated drawings.
- Various other modifications, adaptations, and alternative designs are of course possible in light of the above teachings. Therefore, it should be understood at this time that within the scope of the appended claims the invention might be practiced otherwise than as specifically described herein.
Claims (19)
1. A method to facilitate closure of a PFO in a heart comprising:
introducing a mechanical closure device into an atrium of the heart; and
transeptally deploying the closure device across the septum secundum and septum primum to provide proximation of the septum secundum and septum primum.
2. The method of claim 1 wherein introducing the mechanical closure device into an atrium of the heart comprises a minimally invasive procedure.
3. The method of claim 2 wherein the minimally invasive procedure is a trans-thoracic.
4. The method of claim 3 , wherein the trans-thoracic procedure comprises an atriotomy in an atrial appendage.
5. The method of claim 2 wherein the minimally invasive procedure is an endoscopic procedure.
6. The method of claim 2 wherein the minimally invasive procedure is a laproscopic procedure.
7. The method of claim 2 wherein the minimally invasive procedure is a percutaneous procedure.
8. The method of claim 1 wherein transeptally deploying the closure the device comprises:
penetrating an interatrial septum between a first atrial chamber and a second atrial chamber in the heart;
deploying a distal anchor associated with the closure device into the second atrial chamber;
partially withdrawing the closure device from the second atrial chamber to the first atrial chamber; and
deploying a proximal anchor associated with the closure device into the first atrial chamber.
9. The method of claim 1 wherein transeptally deploying the closure the device comprises:
penetrating an interatrial septum between a first atrial chamber and a second atrial chamber in the heart;
penetrating an interatrial septum between the second atrial chamber and the first atrial chamber in the heart;
deploying a distal anchor associated with the closure device into the first atrial chamber;
partially withdrawing the closure device from the first atrial chamber to the second atrial chamber;
partially withdrawing the closure device from the second atrial chamber to the first atrial chamber; and
deploying a proximal anchor associated with the closure device into the first atrial chamber.
10. The method of claim 8 wherein penetrating the interatrial septum comprises piercing the septum.
11. The method of claim 8 wherein penetrating the interatrial septum comprises non-core cutting of the interatrial septum.
12. The method of claim 8 wherein penetrating the interatrial septum comprises drilling through the septum.
13. The method of claim 8 further comprising adjusting the proximal anchor relative to the distal anchor to enhance proximation.
14. The method of claim 13 wherein adjusting the proximal anchor comprises uni-axially adjusting the proximal anchor relative to a closure line associated with the closure device.
15. The method of claim 14 wherein uni-axially adjusting the proximal anchor comprises non-index adjusting of the proximal anchor relative to the closure line associated with the closure device.
16. The method of claim 14 wherein uni-axially adjusting the proximal anchor comprises incrementally adjusting the proximal anchor relative to the closure line associated with the closure device.
17. The method of claim 1 further comprising assessing the degree of proximation between the septum secundum and septum primum.
18. The method of claim 1 further comprising releasing the closure device from a delivery device.
19. A method to facilitate closure of a PFO in a heart comprising:
introducing a mechanical closure device into an atrium of the heart, the heart having an interatrial septum with a first and a second atrial appendage; and
transeptally deploying the closure device across the first or the second atrial appendage to provide proximation of the first and the second atrial appendages.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/469,653 US20070185530A1 (en) | 2005-09-01 | 2006-09-01 | Patent foramen ovale closure method |
US13/434,266 US9861347B2 (en) | 2005-09-01 | 2012-03-29 | Patent foramen ovale closure method |
US15/845,239 US10945716B2 (en) | 2005-09-01 | 2017-12-18 | Patent foramen ovale closure method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71338805P | 2005-09-01 | 2005-09-01 | |
US11/469,653 US20070185530A1 (en) | 2005-09-01 | 2006-09-01 | Patent foramen ovale closure method |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/434,266 Continuation US9861347B2 (en) | 2005-09-01 | 2012-03-29 | Patent foramen ovale closure method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070185530A1 true US20070185530A1 (en) | 2007-08-09 |
Family
ID=37586451
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/469,653 Abandoned US20070185530A1 (en) | 2005-09-01 | 2006-09-01 | Patent foramen ovale closure method |
US13/434,266 Active 2029-01-11 US9861347B2 (en) | 2005-09-01 | 2012-03-29 | Patent foramen ovale closure method |
US15/845,239 Active 2027-10-04 US10945716B2 (en) | 2005-09-01 | 2017-12-18 | Patent foramen ovale closure method |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/434,266 Active 2029-01-11 US9861347B2 (en) | 2005-09-01 | 2012-03-29 | Patent foramen ovale closure method |
US15/845,239 Active 2027-10-04 US10945716B2 (en) | 2005-09-01 | 2017-12-18 | Patent foramen ovale closure method |
Country Status (4)
Country | Link |
---|---|
US (3) | US20070185530A1 (en) |
AU (1) | AU2006287211B2 (en) |
CA (1) | CA2621197A1 (en) |
WO (1) | WO2007028092A1 (en) |
Cited By (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050267495A1 (en) * | 2004-05-17 | 2005-12-01 | Gateway Medical, Inc. | Systems and methods for closing internal tissue defects |
US20070129755A1 (en) * | 2005-12-05 | 2007-06-07 | Ovalis, Inc. | Clip-based systems and methods for treating septal defects |
US20080065156A1 (en) * | 2006-09-08 | 2008-03-13 | Hauser David L | Expandable clip for tissue repair |
US20080154286A1 (en) * | 2006-12-21 | 2008-06-26 | Ryan Abbott | Systems and Methods for Treating Septal Defects with Capture Devices and Other Devices |
US20090054912A1 (en) * | 2001-09-06 | 2009-02-26 | Heanue Taylor A | Systems and Methods for Treating Septal Defects |
US20090118726A1 (en) * | 2007-10-05 | 2009-05-07 | Coaptus Medical Corporation | Systems and Methods for Transeptal Cardiac Procedures, Including Tissue Sealing Members Associated Methods |
US7678132B2 (en) | 2001-09-06 | 2010-03-16 | Ovalis, Inc. | Systems and methods for treating septal defects |
US7740640B2 (en) | 2001-09-06 | 2010-06-22 | Ovalis, Inc. | Clip apparatus for closing septal defects and methods of use |
US20100185234A1 (en) * | 2009-01-16 | 2010-07-22 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US20110054487A1 (en) * | 2009-09-02 | 2011-03-03 | Circulite, Inc. | Coaxial transseptal guide-wire and needle assembly |
US20110178534A1 (en) * | 2010-01-20 | 2011-07-21 | Whitman Michael P | Tissue repair implant and delivery device and method |
US8070826B2 (en) | 2001-09-07 | 2011-12-06 | Ovalis, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US20110303229A1 (en) * | 2009-12-05 | 2011-12-15 | Integrated Sensing Systems, Inc. | Delivery system, method, and anchor for medical implant placement |
US20120022507A1 (en) * | 2009-12-05 | 2012-01-26 | Integrated Sensing Systems Inc. | Delivery system, method, and anchor for medical implant placement |
US8177809B2 (en) | 2008-09-04 | 2012-05-15 | Curaseal Inc. | Inflatable device for enteric fistula treatment |
US8398656B2 (en) | 2003-01-30 | 2013-03-19 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US8469995B2 (en) | 2002-06-04 | 2013-06-25 | Abbott Vascular Inc. | Blood vessel closure clip and delivery device |
US8486108B2 (en) | 2000-12-07 | 2013-07-16 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US20130197571A1 (en) * | 2011-08-24 | 2013-08-01 | Cardiapex Ltd. | Minimally invasive surgical techniques |
US8518057B2 (en) | 2005-07-01 | 2013-08-27 | Abbott Laboratories | Clip applier and methods of use |
US8518063B2 (en) | 2001-04-24 | 2013-08-27 | Russell A. Houser | Arteriotomy closure devices and techniques |
US8529587B2 (en) | 2003-01-30 | 2013-09-10 | Integrated Vascular Systems, Inc. | Methods of use of a clip applier |
US8556930B2 (en) | 2006-06-28 | 2013-10-15 | Abbott Laboratories | Vessel closure device |
US8579936B2 (en) | 2005-07-05 | 2013-11-12 | ProMed, Inc. | Centering of delivery devices with respect to a septal defect |
US8579932B2 (en) | 2002-02-21 | 2013-11-12 | Integrated Vascular Systems, Inc. | Sheath apparatus and methods for delivering a closure device |
US8585836B2 (en) | 2002-12-31 | 2013-11-19 | Integrated Vascular Systems, Inc. | Methods for manufacturing a clip and clip |
US8590760B2 (en) | 2004-05-25 | 2013-11-26 | Abbott Vascular Inc. | Surgical stapler |
US8597325B2 (en) | 2000-12-07 | 2013-12-03 | Integrated Vascular Systems, Inc. | Apparatus and methods for providing tactile feedback while delivering a closure device |
US8603116B2 (en) | 2010-08-04 | 2013-12-10 | Abbott Cardiovascular Systems, Inc. | Closure device with long tines |
US8657852B2 (en) | 2008-10-30 | 2014-02-25 | Abbott Vascular Inc. | Closure device |
US8672953B2 (en) | 2007-12-17 | 2014-03-18 | Abbott Laboratories | Tissue closure system and methods of use |
US8690910B2 (en) | 2000-12-07 | 2014-04-08 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US8728119B2 (en) | 2001-06-07 | 2014-05-20 | Abbott Vascular Inc. | Surgical staple |
US8758400B2 (en) | 2000-01-05 | 2014-06-24 | Integrated Vascular Systems, Inc. | Closure system and methods of use |
US8758398B2 (en) | 2006-09-08 | 2014-06-24 | Integrated Vascular Systems, Inc. | Apparatus and method for delivering a closure element |
US8758396B2 (en) | 2000-01-05 | 2014-06-24 | Integrated Vascular Systems, Inc. | Vascular sheath with bioabsorbable puncture site closure apparatus and methods of use |
US8758399B2 (en) | 2010-08-02 | 2014-06-24 | Abbott Cardiovascular Systems, Inc. | Expandable bioabsorbable plug apparatus and method |
US8784447B2 (en) | 2000-09-08 | 2014-07-22 | Abbott Vascular Inc. | Surgical stapler |
US8808310B2 (en) | 2006-04-20 | 2014-08-19 | Integrated Vascular Systems, Inc. | Resettable clip applier and reset tools |
US8820602B2 (en) | 2007-12-18 | 2014-09-02 | Abbott Laboratories | Modular clip applier |
US8858594B2 (en) | 2008-12-22 | 2014-10-14 | Abbott Laboratories | Curved closure device |
US8893947B2 (en) | 2007-12-17 | 2014-11-25 | Abbott Laboratories | Clip applier and methods of use |
US8905937B2 (en) | 2009-02-26 | 2014-12-09 | Integrated Vascular Systems, Inc. | Methods and apparatus for locating a surface of a body lumen |
US8926633B2 (en) | 2005-06-24 | 2015-01-06 | Abbott Laboratories | Apparatus and method for delivering a closure element |
US8926656B2 (en) | 2003-01-30 | 2015-01-06 | Integated Vascular Systems, Inc. | Clip applier and methods of use |
US8956388B2 (en) | 2000-01-05 | 2015-02-17 | Integrated Vascular Systems, Inc. | Integrated vascular device with puncture site closure component and sealant |
US8961541B2 (en) | 2007-12-03 | 2015-02-24 | Cardio Vascular Technologies Inc. | Vascular closure devices, systems, and methods of use |
US8992567B1 (en) | 2001-04-24 | 2015-03-31 | Cardiovascular Technologies Inc. | Compressible, deformable, or deflectable tissue closure devices and method of manufacture |
US9089674B2 (en) | 2000-10-06 | 2015-07-28 | Integrated Vascular Systems, Inc. | Apparatus and methods for positioning a vascular sheath |
US9089311B2 (en) | 2009-01-09 | 2015-07-28 | Abbott Vascular Inc. | Vessel closure devices and methods |
US9131941B2 (en) | 2011-06-17 | 2015-09-15 | Curaseal Inc. | Fistula treatment devices and methods |
US9149276B2 (en) | 2011-03-21 | 2015-10-06 | Abbott Cardiovascular Systems, Inc. | Clip and deployment apparatus for tissue closure |
US9173644B2 (en) | 2009-01-09 | 2015-11-03 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US9211116B2 (en) | 2011-06-16 | 2015-12-15 | Curaseal Inc. | Fistula treatment devices and related methods |
US20160015376A1 (en) * | 2014-07-20 | 2016-01-21 | New York University | Anchored suture line, device and method for surgical suturing |
US9282965B2 (en) | 2008-05-16 | 2016-03-15 | Abbott Laboratories | Apparatus and methods for engaging tissue |
US9314230B2 (en) | 2009-01-09 | 2016-04-19 | Abbott Vascular Inc. | Closure device with rapidly eroding anchor |
US9332976B2 (en) | 2011-11-30 | 2016-05-10 | Abbott Cardiovascular Systems, Inc. | Tissue closure device |
US9345460B2 (en) | 2001-04-24 | 2016-05-24 | Cardiovascular Technologies, Inc. | Tissue closure devices, device and systems for delivery, kits and methods therefor |
US9364209B2 (en) | 2012-12-21 | 2016-06-14 | Abbott Cardiovascular Systems, Inc. | Articulating suturing device |
US9414820B2 (en) | 2009-01-09 | 2016-08-16 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US9486191B2 (en) | 2009-01-09 | 2016-11-08 | Abbott Vascular, Inc. | Closure devices |
US9579091B2 (en) | 2000-01-05 | 2017-02-28 | Integrated Vascular Systems, Inc. | Closure system and methods of use |
US9585647B2 (en) | 2009-08-26 | 2017-03-07 | Abbott Laboratories | Medical device for repairing a fistula |
US9980708B2 (en) | 2010-01-20 | 2018-05-29 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US10058314B2 (en) | 2010-01-20 | 2018-08-28 | Micro Interventional Devices, Inc. | Tissue closure device and method |
WO2019232068A1 (en) * | 2018-05-29 | 2019-12-05 | Paul Sorajja | Method and system for closure of cardiovascular apertures |
US10743854B2 (en) | 2010-01-20 | 2020-08-18 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US10959840B2 (en) | 2010-01-20 | 2021-03-30 | Micro Interventional Devices, Inc. | Systems and methods for affixing a prosthesis to tissue |
US11304691B2 (en) | 2016-11-13 | 2022-04-19 | Anchora Medical Ltd. | Minimally-invasive tissue suturing device |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9861346B2 (en) | 2003-07-14 | 2018-01-09 | W. L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
US8167894B2 (en) | 2006-08-09 | 2012-05-01 | Coherex Medical, Inc. | Methods, systems and devices for reducing the size of an internal tissue opening |
US9138208B2 (en) | 2006-08-09 | 2015-09-22 | Coherex Medical, Inc. | Devices for reducing the size of an internal tissue opening |
US8529597B2 (en) | 2006-08-09 | 2013-09-10 | Coherex Medical, Inc. | Devices for reducing the size of an internal tissue opening |
WO2008124603A1 (en) | 2007-04-05 | 2008-10-16 | Nmt Medical, Inc. | Septal closure device with centering mechanism |
US20130165967A1 (en) | 2008-03-07 | 2013-06-27 | W.L. Gore & Associates, Inc. | Heart occlusion devices |
US8956389B2 (en) | 2009-06-22 | 2015-02-17 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US9381006B2 (en) | 2009-06-22 | 2016-07-05 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US20120029556A1 (en) | 2009-06-22 | 2012-02-02 | Masters Steven J | Sealing device and delivery system |
DE102009036817A1 (en) | 2009-08-10 | 2011-02-17 | Acoredis Gmbh | Occlusion device, useful e.g. for closing the heart defects in a patient and other abnormal body openings, comprises mesh of fibers or film body of highly flexible, elastic materials, where the device is introduced through e.g. catheter |
US8870950B2 (en) | 2009-12-08 | 2014-10-28 | Mitral Tech Ltd. | Rotation-based anchoring of an implant |
WO2011111047A2 (en) | 2010-03-10 | 2011-09-15 | Mitraltech Ltd. | Prosthetic mitral valve with tissue anchors |
US9763657B2 (en) | 2010-07-21 | 2017-09-19 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US8992604B2 (en) | 2010-07-21 | 2015-03-31 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US9132009B2 (en) | 2010-07-21 | 2015-09-15 | Mitraltech Ltd. | Guide wires with commissural anchors to advance a prosthetic valve |
US20140324164A1 (en) | 2011-08-05 | 2014-10-30 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
WO2013021374A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
US8852272B2 (en) | 2011-08-05 | 2014-10-07 | Mitraltech Ltd. | Techniques for percutaneous mitral valve replacement and sealing |
WO2013021375A2 (en) | 2011-08-05 | 2013-02-14 | Mitraltech Ltd. | Percutaneous mitral valve replacement and sealing |
US9770232B2 (en) | 2011-08-12 | 2017-09-26 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
WO2013081905A1 (en) | 2011-11-28 | 2013-06-06 | St. Jude Medical Puerto Rico Llc | Anchor device for large bore vascular closure |
US20140114346A1 (en) * | 2012-10-23 | 2014-04-24 | Medtronic, Inc. | Transapical Entry Point Closure Device |
US10828019B2 (en) | 2013-01-18 | 2020-11-10 | W.L. Gore & Associates, Inc. | Sealing device and delivery system |
EP2948103B1 (en) | 2013-01-24 | 2022-12-07 | Cardiovalve Ltd | Ventricularly-anchored prosthetic valves |
JP6473140B2 (en) * | 2013-05-07 | 2019-02-20 | アムセル メディカル コーポレイション | Method and apparatus for clamping a layer of tissue and occluding a tubular body cavity |
US9808230B2 (en) | 2014-06-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US10524910B2 (en) | 2014-07-30 | 2020-01-07 | Mitraltech Ltd. 3 Ariel Sharon Avenue | Articulatable prosthetic valve |
CN107205818B (en) | 2015-02-05 | 2019-05-10 | 卡迪尔维尔福股份有限公司 | Artificial valve with the frame that slides axially |
US9974651B2 (en) | 2015-02-05 | 2018-05-22 | Mitral Tech Ltd. | Prosthetic valve with axially-sliding frames |
US10531866B2 (en) | 2016-02-16 | 2020-01-14 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
CN114587712A (en) | 2016-08-10 | 2022-06-07 | 卡迪尔维尔福股份有限公司 | Prosthetic valve with coaxial frame |
USD800908S1 (en) | 2016-08-10 | 2017-10-24 | Mitraltech Ltd. | Prosthetic valve element |
US10537426B2 (en) | 2017-08-03 | 2020-01-21 | Cardiovalve Ltd. | Prosthetic heart valve |
US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
US10575948B2 (en) | 2017-08-03 | 2020-03-03 | Cardiovalve Ltd. | Prosthetic heart valve |
US10888421B2 (en) | 2017-09-19 | 2021-01-12 | Cardiovalve Ltd. | Prosthetic heart valve with pouch |
US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
GB201720803D0 (en) | 2017-12-13 | 2018-01-24 | Mitraltech Ltd | Prosthetic Valve and delivery tool therefor |
GB201800399D0 (en) | 2018-01-10 | 2018-02-21 | Mitraltech Ltd | Temperature-control during crimping of an implant |
WO2021217055A1 (en) | 2020-04-23 | 2021-10-28 | Shifamed Holdings, Llc | Intracardiac sensors with switchable configurations and associated systems and methods |
CN116367795A (en) | 2020-08-25 | 2023-06-30 | 施菲姆德控股有限责任公司 | Adjustable interatrial shunt and associated systems and methods |
US11857197B2 (en) | 2020-11-12 | 2024-01-02 | Shifamed Holdings, Llc | Adjustable implantable devices and associated methods |
Citations (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3874388A (en) * | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
US4917089A (en) * | 1988-08-29 | 1990-04-17 | Sideris Eleftherios B | Buttoned device for the transvenous occlusion of intracardiac defects |
US5171259A (en) * | 1990-04-02 | 1992-12-15 | Kanji Inoue | Device for nonoperatively occluding a defect |
US5284488A (en) * | 1992-12-23 | 1994-02-08 | Sideris Eleftherios B | Adjustable devices for the occlusion of cardiac defects |
US5433727A (en) * | 1994-08-16 | 1995-07-18 | Sideris; Eleftherios B. | Centering buttoned device for the occlusion of large defects for occluding |
US6080182A (en) * | 1996-12-20 | 2000-06-27 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US6171329B1 (en) * | 1994-12-19 | 2001-01-09 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US6436088B2 (en) * | 1999-09-20 | 2002-08-20 | Appriva Medical, Inc. | Method and apparatus for closing a subcutaneous tissue opening |
US20020183787A1 (en) * | 2001-06-01 | 2002-12-05 | Velocimed, L.L.C. | Closure devices, related delivery methods and tools, and related methods of use |
US6508828B1 (en) * | 2000-11-03 | 2003-01-21 | Radi Medical Systems Ab | Sealing device and wound closure device |
US20030144694A1 (en) * | 2002-01-14 | 2003-07-31 | Nmt Medical, Inc. | Patent foramen ovale (PFO) closure method and device |
US6616684B1 (en) * | 2000-10-06 | 2003-09-09 | Myocor, Inc. | Endovascular splinting devices and methods |
US20040127917A1 (en) * | 2001-09-07 | 2004-07-01 | Ginn Richard S. | Needle apparatus for closing septal defects and methods for using such apparatus |
US20040176799A1 (en) * | 2002-12-09 | 2004-09-09 | Nmt Medical, Inc. | Septal closure devices |
US20040243122A1 (en) * | 2003-02-13 | 2004-12-02 | Coaptus Medical Corporation | Transseptal closure of a patent foramen ovale and other cardiac defects |
US20050059984A1 (en) * | 2003-09-11 | 2005-03-17 | Andrzej Chanduszko | Devices, systems, and methods for suturing tissue |
US20050101984A1 (en) * | 2003-11-06 | 2005-05-12 | Nmt Medical, Inc. | Transseptal puncture apparatus |
US20050119675A1 (en) * | 2003-10-24 | 2005-06-02 | Adams Daniel O. | Patent foramen ovale closure system |
US20050125032A1 (en) * | 2003-10-10 | 2005-06-09 | Whisenant Brian K. | Patent foramen ovale (PFO) closure devices, delivery apparatus and related methods and systems |
US6911037B2 (en) * | 1999-09-07 | 2005-06-28 | Ev3, Inc. | Retrievable septal defect closure device |
US6913614B2 (en) * | 2003-05-08 | 2005-07-05 | Cardia, Inc. | Delivery system with safety tether |
US20050187568A1 (en) * | 2004-02-20 | 2005-08-25 | Klenk Alan R. | Devices and methods for closing a patent foramen ovale with a coil-shaped closure device |
US20050267523A1 (en) * | 2004-03-03 | 2005-12-01 | Nmt Medical Inc. | Delivery/recovery system for septal occluder |
US20050277983A1 (en) * | 2004-06-09 | 2005-12-15 | Usgi Medical Inc. | System for optimizing anchoring force |
US20060036584A1 (en) * | 2004-08-10 | 2006-02-16 | Fujitsu Limited | Identification mark registration method, electronic apparatus and computer-readable storage medium |
Family Cites Families (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3452740A (en) | 1966-05-31 | 1969-07-01 | Us Catheter & Instr Corp | Spring guide manipulator |
US3847156A (en) | 1972-07-17 | 1974-11-12 | Sherwood Medical Ind Inc | Suture |
US4007743A (en) | 1975-10-20 | 1977-02-15 | American Hospital Supply Corporation | Opening mechanism for umbrella-like intravascular shunt defect closure device |
US4235238A (en) | 1978-05-11 | 1980-11-25 | Olympus Optical Co., Ltd. | Apparatus for suturing coeliac tissues |
US5102419A (en) | 1978-12-08 | 1992-04-07 | Ethicon, Inc. | Elastomeric surgical sutures comprising segmented copolyether/esters |
US4710192A (en) | 1985-12-30 | 1987-12-01 | Liotta Domingo S | Diaphragm and method for occlusion of the descending thoracic aorta |
US4744364A (en) | 1987-02-17 | 1988-05-17 | Intravascular Surgical Instruments, Inc. | Device for sealing percutaneous puncture in a vessel |
US5372146A (en) | 1990-11-06 | 1994-12-13 | Branch; Thomas P. | Method and apparatus for re-approximating tissue |
US5108420A (en) | 1991-02-01 | 1992-04-28 | Temple University | Aperture occlusion device |
US5242410A (en) | 1991-04-15 | 1993-09-07 | University Of Florida | Wireless high flow intravascular sheath introducer and method |
CA2078530A1 (en) | 1991-09-23 | 1993-03-24 | Jay Erlebacher | Percutaneous arterial puncture seal device and insertion tool therefore |
US5290310A (en) | 1991-10-30 | 1994-03-01 | Howmedica, Inc. | Hemostatic implant introducer |
DE69229539T2 (en) | 1991-11-05 | 2000-02-17 | Childrens Medical Center | Occlusion device for repairing heart and vascular defects |
US5305788A (en) | 1992-08-13 | 1994-04-26 | Whitey Co. | Stream selector for process analyzer |
US5342393A (en) | 1992-08-27 | 1994-08-30 | Duke University | Method and device for vascular repair |
US5797960A (en) | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
US5601571A (en) | 1994-05-17 | 1997-02-11 | Moss; Gerald | Surgical fastener implantation device |
US5688451A (en) | 1995-01-03 | 1997-11-18 | American Cyanamid Company | Method of forming an absorbable biocompatible suture yarn |
DK175166B1 (en) | 1995-01-03 | 2004-06-21 | Cook William Europ | Method of manufacturing an assembly for placing an embolization coil in the vascular system and such assembly as well as an apparatus for advancing the assembly |
US5702421A (en) | 1995-01-11 | 1997-12-30 | Schneidt; Bernhard | Closure device for closing a vascular opening, such as patent ductus arteriosus |
CA2178541C (en) | 1995-06-07 | 2009-11-24 | Neal E. Fearnot | Implantable medical device |
US5853422A (en) | 1996-03-22 | 1998-12-29 | Scimed Life Systems, Inc. | Apparatus and method for closing a septal defect |
US5725521A (en) | 1996-03-29 | 1998-03-10 | Eclipse Surgical Technologies, Inc. | Depth stop apparatus and method for laser-assisted transmyocardial revascularization and other surgical applications |
GB9614950D0 (en) | 1996-07-16 | 1996-09-04 | Anson Medical Ltd | A ductus stent and delivery catheter |
US5861003A (en) | 1996-10-23 | 1999-01-19 | The Cleveland Clinic Foundation | Apparatus and method for occluding a defect or aperture within body surface |
US5976174A (en) | 1997-12-15 | 1999-11-02 | Ruiz; Carlos E. | Medical hole closure device and methods of use |
US5944738A (en) | 1998-02-06 | 1999-08-31 | Aga Medical Corporation | Percutaneous catheter directed constricting occlusion device |
US20050119615A1 (en) | 2000-04-06 | 2005-06-02 | Norborn Medical, Inc. | Guidewire for crossing occlusions or stenoses |
US6152144A (en) | 1998-11-06 | 2000-11-28 | Appriva Medical, Inc. | Method and device for left atrial appendage occlusion |
WO2000060995A2 (en) | 1999-04-09 | 2000-10-19 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US7955340B2 (en) | 1999-06-25 | 2011-06-07 | Usgi Medical, Inc. | Apparatus and methods for forming and securing gastrointestinal tissue folds |
US6626899B2 (en) | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
US7160312B2 (en) | 1999-06-25 | 2007-01-09 | Usgi Medical, Inc. | Implantable artificial partition and methods of use |
US6458140B2 (en) | 1999-07-28 | 2002-10-01 | Vasconnect, Inc. | Devices and methods for interconnecting vessels |
US7303526B2 (en) | 1999-08-09 | 2007-12-04 | Cardiokinetix, Inc. | Device for improving cardiac function |
US8257428B2 (en) | 1999-08-09 | 2012-09-04 | Cardiokinetix, Inc. | System for improving cardiac function |
EP1225948B1 (en) | 1999-09-20 | 2007-08-08 | ev3 Endovascular, Inc. | Apparatus for closing a body lumen |
US6689150B1 (en) | 1999-10-27 | 2004-02-10 | Atritech, Inc. | Filter apparatus for ostium of left atrial appendage |
DE10000137A1 (en) | 2000-01-04 | 2001-07-12 | Pfm Prod Fuer Die Med Ag | Implantate for closing defect apertures in human or animal bodies, bearing structure of which can be reversed from secondary to primary form by elastic force |
EP1409058A2 (en) | 2000-01-28 | 2004-04-21 | William Cook Europe ApS | Endovascular medical device with plurality of wires |
US6312438B1 (en) | 2000-02-01 | 2001-11-06 | Medtronic Xomed, Inc. | Rotary bur instruments having bur tips with aspiration passages |
ITPC20000013A1 (en) | 2000-04-13 | 2000-07-13 | Paolo Ferrazzi | INTROVENTRICULAR DEVICE AND RELATED METHOD FOR THE TREATMENT AND CORRECTION OF MYOCARDIOPATHIES. |
US20060030881A1 (en) | 2004-08-05 | 2006-02-09 | Cardiokinetix, Inc. | Ventricular partitioning device |
US7422579B2 (en) | 2001-05-01 | 2008-09-09 | St. Jude Medical Cardiology Divison, Inc. | Emboli protection devices and related methods of use |
US7374560B2 (en) | 2001-05-01 | 2008-05-20 | St. Jude Medical, Cardiology Division, Inc. | Emboli protection devices and related methods of use |
US7604612B2 (en) | 2001-05-01 | 2009-10-20 | St. Jude Medical, Cardiology Division, Inc. | Emboli protection devices and related methods of use |
US20020165774A1 (en) | 2001-05-03 | 2002-11-07 | Quinn Gaellen D. | Offline-to-online traffic generation and demographic identification process and method |
US7288105B2 (en) | 2001-08-01 | 2007-10-30 | Ev3 Endovascular, Inc. | Tissue opening occluder |
US6776784B2 (en) | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
US20050267495A1 (en) | 2004-05-17 | 2005-12-01 | Gateway Medical, Inc. | Systems and methods for closing internal tissue defects |
AU2002323634A1 (en) | 2001-09-06 | 2003-03-24 | Nmt Medical, Inc. | Flexible delivery system |
US20070129755A1 (en) | 2005-12-05 | 2007-06-07 | Ovalis, Inc. | Clip-based systems and methods for treating septal defects |
US20060052821A1 (en) | 2001-09-06 | 2006-03-09 | Ovalis, Inc. | Systems and methods for treating septal defects |
AU2002360695A1 (en) | 2001-12-19 | 2003-07-09 | Nmt Medical, Inc. | Septal occluder and associated methods |
US7318833B2 (en) | 2001-12-19 | 2008-01-15 | Nmt Medical, Inc. | PFO closure device with flexible thrombogenic joint and improved dislodgement resistance |
DE10219860A1 (en) | 2002-05-03 | 2003-11-20 | Ethicon Gmbh | Surgical thread and surgical implant with such a thread |
US7976564B2 (en) | 2002-05-06 | 2011-07-12 | St. Jude Medical, Cardiology Division, Inc. | PFO closure devices and related methods of use |
JP2005528181A (en) * | 2002-06-05 | 2005-09-22 | エヌエムティー メディカル インコーポレイテッド | Patent foramen ovale (PFO) occlusion device with radial and circumferential supports |
US7101395B2 (en) | 2002-06-12 | 2006-09-05 | Mitral Interventions, Inc. | Method and apparatus for tissue connection |
US20040044364A1 (en) | 2002-08-29 | 2004-03-04 | Devries Robert | Tissue fasteners and related deployment systems and methods |
CA2499753A1 (en) | 2002-09-23 | 2004-04-01 | Nmt Medical, Inc. | Septal puncture device |
US20040254594A1 (en) | 2003-01-24 | 2004-12-16 | Arthur Alfaro | Cardiac defect occlusion device |
WO2004069055A2 (en) | 2003-02-04 | 2004-08-19 | Ev3 Sunnyvale Inc. | Patent foramen ovale closure system |
US8372112B2 (en) | 2003-04-11 | 2013-02-12 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods, and related methods of use |
US20040267306A1 (en) | 2003-04-11 | 2004-12-30 | Velocimed, L.L.C. | Closure devices, related delivery methods, and related methods of use |
JP4166632B2 (en) | 2003-06-06 | 2008-10-15 | オリンパス株式会社 | Suture device |
CA2532112C (en) | 2003-07-14 | 2012-09-18 | Nmt Medical, Inc. | Tubular patent foramen ovale (pfo) closure device with catch system |
US8114123B2 (en) * | 2003-09-19 | 2012-02-14 | St. Jude Medical, Inc. | Apparatus and methods for tissue gathering and securing |
US20050075654A1 (en) | 2003-10-06 | 2005-04-07 | Brian Kelleher | Methods and devices for soft tissue securement |
JP2005160648A (en) | 2003-12-01 | 2005-06-23 | Terumo Corp | Wire and medical instrument for removing foreign body in blood vessel |
US20050256532A1 (en) | 2004-05-12 | 2005-11-17 | Asha Nayak | Cardiovascular defect patch device and method |
AU2005247337A1 (en) | 2004-05-24 | 2005-12-08 | Juvent, Inc. | Assisted-standing gear for use with dynamic-motion plates |
US8206417B2 (en) | 2004-06-09 | 2012-06-26 | Usgi Medical Inc. | Apparatus and methods for optimizing anchoring force |
US8636694B2 (en) | 2004-06-14 | 2014-01-28 | Medtronic, Inc. | Modular medical injection system |
EP1827247B8 (en) * | 2004-09-24 | 2020-05-06 | W.L. Gore & Associates, Inc. | Occluder device double securement system for delivery/recovery of such occluder device |
US7758594B2 (en) | 2005-05-20 | 2010-07-20 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
WO2007008565A1 (en) * | 2005-07-07 | 2007-01-18 | Cordis Corporation | Patent foramen ovale closure device with steerable delivery system |
-
2006
- 2006-09-01 AU AU2006287211A patent/AU2006287211B2/en not_active Ceased
- 2006-09-01 CA CA002621197A patent/CA2621197A1/en not_active Abandoned
- 2006-09-01 WO PCT/US2006/034348 patent/WO2007028092A1/en active Application Filing
- 2006-09-01 US US11/469,653 patent/US20070185530A1/en not_active Abandoned
-
2012
- 2012-03-29 US US13/434,266 patent/US9861347B2/en active Active
-
2017
- 2017-12-18 US US15/845,239 patent/US10945716B2/en active Active
Patent Citations (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3874388A (en) * | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
US4917089A (en) * | 1988-08-29 | 1990-04-17 | Sideris Eleftherios B | Buttoned device for the transvenous occlusion of intracardiac defects |
US5171259A (en) * | 1990-04-02 | 1992-12-15 | Kanji Inoue | Device for nonoperatively occluding a defect |
US5284488A (en) * | 1992-12-23 | 1994-02-08 | Sideris Eleftherios B | Adjustable devices for the occlusion of cardiac defects |
US5433727A (en) * | 1994-08-16 | 1995-07-18 | Sideris; Eleftherios B. | Centering buttoned device for the occlusion of large defects for occluding |
US6171329B1 (en) * | 1994-12-19 | 2001-01-09 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US6623508B2 (en) * | 1996-12-20 | 2003-09-23 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US6080182A (en) * | 1996-12-20 | 2000-06-27 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US6911037B2 (en) * | 1999-09-07 | 2005-06-28 | Ev3, Inc. | Retrievable septal defect closure device |
US6436088B2 (en) * | 1999-09-20 | 2002-08-20 | Appriva Medical, Inc. | Method and apparatus for closing a subcutaneous tissue opening |
US6616684B1 (en) * | 2000-10-06 | 2003-09-09 | Myocor, Inc. | Endovascular splinting devices and methods |
US6508828B1 (en) * | 2000-11-03 | 2003-01-21 | Radi Medical Systems Ab | Sealing device and wound closure device |
US20020183787A1 (en) * | 2001-06-01 | 2002-12-05 | Velocimed, L.L.C. | Closure devices, related delivery methods and tools, and related methods of use |
US20060036282A1 (en) * | 2001-06-01 | 2006-02-16 | Velocimed Pfo, Inc. | Closure devices, related delivery methods and tools, and related methods of use |
US20040127917A1 (en) * | 2001-09-07 | 2004-07-01 | Ginn Richard S. | Needle apparatus for closing septal defects and methods for using such apparatus |
US20030144694A1 (en) * | 2002-01-14 | 2003-07-31 | Nmt Medical, Inc. | Patent foramen ovale (PFO) closure method and device |
US20040176799A1 (en) * | 2002-12-09 | 2004-09-09 | Nmt Medical, Inc. | Septal closure devices |
US20040243122A1 (en) * | 2003-02-13 | 2004-12-02 | Coaptus Medical Corporation | Transseptal closure of a patent foramen ovale and other cardiac defects |
US6913614B2 (en) * | 2003-05-08 | 2005-07-05 | Cardia, Inc. | Delivery system with safety tether |
US20050059984A1 (en) * | 2003-09-11 | 2005-03-17 | Andrzej Chanduszko | Devices, systems, and methods for suturing tissue |
US20050125032A1 (en) * | 2003-10-10 | 2005-06-09 | Whisenant Brian K. | Patent foramen ovale (PFO) closure devices, delivery apparatus and related methods and systems |
US20050119675A1 (en) * | 2003-10-24 | 2005-06-02 | Adams Daniel O. | Patent foramen ovale closure system |
US20050101984A1 (en) * | 2003-11-06 | 2005-05-12 | Nmt Medical, Inc. | Transseptal puncture apparatus |
US20050187568A1 (en) * | 2004-02-20 | 2005-08-25 | Klenk Alan R. | Devices and methods for closing a patent foramen ovale with a coil-shaped closure device |
US20050267523A1 (en) * | 2004-03-03 | 2005-12-01 | Nmt Medical Inc. | Delivery/recovery system for septal occluder |
US20050277983A1 (en) * | 2004-06-09 | 2005-12-15 | Usgi Medical Inc. | System for optimizing anchoring force |
US20060036584A1 (en) * | 2004-08-10 | 2006-02-16 | Fujitsu Limited | Identification mark registration method, electronic apparatus and computer-readable storage medium |
Cited By (119)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9579091B2 (en) | 2000-01-05 | 2017-02-28 | Integrated Vascular Systems, Inc. | Closure system and methods of use |
US8758400B2 (en) | 2000-01-05 | 2014-06-24 | Integrated Vascular Systems, Inc. | Closure system and methods of use |
US8758396B2 (en) | 2000-01-05 | 2014-06-24 | Integrated Vascular Systems, Inc. | Vascular sheath with bioabsorbable puncture site closure apparatus and methods of use |
US8956388B2 (en) | 2000-01-05 | 2015-02-17 | Integrated Vascular Systems, Inc. | Integrated vascular device with puncture site closure component and sealant |
US9050087B2 (en) | 2000-01-05 | 2015-06-09 | Integrated Vascular Systems, Inc. | Integrated vascular device with puncture site closure component and sealant and methods of use |
US10111664B2 (en) | 2000-01-05 | 2018-10-30 | Integrated Vascular Systems, Inc. | Closure system and methods of use |
US8784447B2 (en) | 2000-09-08 | 2014-07-22 | Abbott Vascular Inc. | Surgical stapler |
US9060769B2 (en) | 2000-09-08 | 2015-06-23 | Abbott Vascular Inc. | Surgical stapler |
US9402625B2 (en) | 2000-09-08 | 2016-08-02 | Abbott Vascular Inc. | Surgical stapler |
US9089674B2 (en) | 2000-10-06 | 2015-07-28 | Integrated Vascular Systems, Inc. | Apparatus and methods for positioning a vascular sheath |
US9585646B2 (en) | 2000-12-07 | 2017-03-07 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US8486108B2 (en) | 2000-12-07 | 2013-07-16 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US8690910B2 (en) | 2000-12-07 | 2014-04-08 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US9554786B2 (en) | 2000-12-07 | 2017-01-31 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US10245013B2 (en) | 2000-12-07 | 2019-04-02 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US8603136B2 (en) | 2000-12-07 | 2013-12-10 | Integrated Vascular Systems, Inc. | Apparatus and methods for providing tactile feedback while delivering a closure device |
US8597325B2 (en) | 2000-12-07 | 2013-12-03 | Integrated Vascular Systems, Inc. | Apparatus and methods for providing tactile feedback while delivering a closure device |
US9320522B2 (en) | 2000-12-07 | 2016-04-26 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US8486092B2 (en) | 2000-12-07 | 2013-07-16 | Integrated Vascular Systems, Inc. | Closure device and methods for making and using them |
US9345460B2 (en) | 2001-04-24 | 2016-05-24 | Cardiovascular Technologies, Inc. | Tissue closure devices, device and systems for delivery, kits and methods therefor |
US8992567B1 (en) | 2001-04-24 | 2015-03-31 | Cardiovascular Technologies Inc. | Compressible, deformable, or deflectable tissue closure devices and method of manufacture |
US8518063B2 (en) | 2001-04-24 | 2013-08-27 | Russell A. Houser | Arteriotomy closure devices and techniques |
US8728119B2 (en) | 2001-06-07 | 2014-05-20 | Abbott Vascular Inc. | Surgical staple |
US7678132B2 (en) | 2001-09-06 | 2010-03-16 | Ovalis, Inc. | Systems and methods for treating septal defects |
US20090054912A1 (en) * | 2001-09-06 | 2009-02-26 | Heanue Taylor A | Systems and Methods for Treating Septal Defects |
US7686828B2 (en) | 2001-09-06 | 2010-03-30 | Ovalis, Inc. | Systems and methods for treating septal defects |
US8758401B2 (en) | 2001-09-06 | 2014-06-24 | ProMed, Inc. | Systems and methods for treating septal defects |
US7740640B2 (en) | 2001-09-06 | 2010-06-22 | Ovalis, Inc. | Clip apparatus for closing septal defects and methods of use |
US8747483B2 (en) | 2001-09-07 | 2014-06-10 | ProMed, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US8070826B2 (en) | 2001-09-07 | 2011-12-06 | Ovalis, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US8579932B2 (en) | 2002-02-21 | 2013-11-12 | Integrated Vascular Systems, Inc. | Sheath apparatus and methods for delivering a closure device |
US10201340B2 (en) | 2002-02-21 | 2019-02-12 | Integrated Vascular Systems, Inc. | Sheath apparatus and methods for delivering a closure device |
US9498196B2 (en) | 2002-02-21 | 2016-11-22 | Integrated Vascular Systems, Inc. | Sheath apparatus and methods for delivering a closure device |
US9295469B2 (en) | 2002-06-04 | 2016-03-29 | Abbott Vascular Inc. | Blood vessel closure clip and delivery device |
US9980728B2 (en) | 2002-06-04 | 2018-05-29 | Abbott Vascular Inc | Blood vessel closure clip and delivery device |
US8469995B2 (en) | 2002-06-04 | 2013-06-25 | Abbott Vascular Inc. | Blood vessel closure clip and delivery device |
US8585836B2 (en) | 2002-12-31 | 2013-11-19 | Integrated Vascular Systems, Inc. | Methods for manufacturing a clip and clip |
US9271707B2 (en) | 2003-01-30 | 2016-03-01 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US8926656B2 (en) | 2003-01-30 | 2015-01-06 | Integated Vascular Systems, Inc. | Clip applier and methods of use |
US9398914B2 (en) | 2003-01-30 | 2016-07-26 | Integrated Vascular Systems, Inc. | Methods of use of a clip applier |
US10398418B2 (en) | 2003-01-30 | 2019-09-03 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US11589856B2 (en) | 2003-01-30 | 2023-02-28 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US8529587B2 (en) | 2003-01-30 | 2013-09-10 | Integrated Vascular Systems, Inc. | Methods of use of a clip applier |
US8398656B2 (en) | 2003-01-30 | 2013-03-19 | Integrated Vascular Systems, Inc. | Clip applier and methods of use |
US20050267495A1 (en) * | 2004-05-17 | 2005-12-01 | Gateway Medical, Inc. | Systems and methods for closing internal tissue defects |
US8590760B2 (en) | 2004-05-25 | 2013-11-26 | Abbott Vascular Inc. | Surgical stapler |
US8926633B2 (en) | 2005-06-24 | 2015-01-06 | Abbott Laboratories | Apparatus and method for delivering a closure element |
US10085753B2 (en) | 2005-07-01 | 2018-10-02 | Abbott Laboratories | Clip applier and methods of use |
US11344304B2 (en) | 2005-07-01 | 2022-05-31 | Abbott Laboratories | Clip applier and methods of use |
US9050068B2 (en) | 2005-07-01 | 2015-06-09 | Abbott Laboratories | Clip applier and methods of use |
US8518057B2 (en) | 2005-07-01 | 2013-08-27 | Abbott Laboratories | Clip applier and methods of use |
US8579936B2 (en) | 2005-07-05 | 2013-11-12 | ProMed, Inc. | Centering of delivery devices with respect to a septal defect |
US20070129755A1 (en) * | 2005-12-05 | 2007-06-07 | Ovalis, Inc. | Clip-based systems and methods for treating septal defects |
US8808310B2 (en) | 2006-04-20 | 2014-08-19 | Integrated Vascular Systems, Inc. | Resettable clip applier and reset tools |
US9962144B2 (en) | 2006-06-28 | 2018-05-08 | Abbott Laboratories | Vessel closure device |
US8556930B2 (en) | 2006-06-28 | 2013-10-15 | Abbott Laboratories | Vessel closure device |
US8758398B2 (en) | 2006-09-08 | 2014-06-24 | Integrated Vascular Systems, Inc. | Apparatus and method for delivering a closure element |
US9301749B2 (en) | 2006-09-08 | 2016-04-05 | Edwards Lifesciences Corporation | Expandable clip for tissue repair |
US20080065156A1 (en) * | 2006-09-08 | 2008-03-13 | Hauser David L | Expandable clip for tissue repair |
US20080154286A1 (en) * | 2006-12-21 | 2008-06-26 | Ryan Abbott | Systems and Methods for Treating Septal Defects with Capture Devices and Other Devices |
US20090118726A1 (en) * | 2007-10-05 | 2009-05-07 | Coaptus Medical Corporation | Systems and Methods for Transeptal Cardiac Procedures, Including Tissue Sealing Members Associated Methods |
US8308763B2 (en) | 2007-10-05 | 2012-11-13 | Coaptus Medical Corporation | Systems and methods for transeptal cardiac procedures, including separable guidewires |
US8235986B2 (en) | 2007-10-05 | 2012-08-07 | Coaptus Medical Corporation | Systems and methods for transeptal cardiac procedures, including tissue penetrating members and associated methods |
US8961541B2 (en) | 2007-12-03 | 2015-02-24 | Cardio Vascular Technologies Inc. | Vascular closure devices, systems, and methods of use |
US8893947B2 (en) | 2007-12-17 | 2014-11-25 | Abbott Laboratories | Clip applier and methods of use |
US8672953B2 (en) | 2007-12-17 | 2014-03-18 | Abbott Laboratories | Tissue closure system and methods of use |
US8820602B2 (en) | 2007-12-18 | 2014-09-02 | Abbott Laboratories | Modular clip applier |
US10413295B2 (en) | 2008-05-16 | 2019-09-17 | Abbott Laboratories | Engaging element for engaging tissue |
US9282965B2 (en) | 2008-05-16 | 2016-03-15 | Abbott Laboratories | Apparatus and methods for engaging tissue |
US9993235B2 (en) | 2008-09-04 | 2018-06-12 | Curaseal Inc. | Enteric fistula treatment devices |
US8377094B2 (en) | 2008-09-04 | 2013-02-19 | Curaseal Inc. | Enteric fistula treatment devices |
US8177809B2 (en) | 2008-09-04 | 2012-05-15 | Curaseal Inc. | Inflatable device for enteric fistula treatment |
US8206416B2 (en) | 2008-09-04 | 2012-06-26 | Curaseal Inc. | Inflatable device for enteric fistula treatment |
US8221451B2 (en) | 2008-09-04 | 2012-07-17 | Curaseal Inc. | Inflatable device for enteric fistula treatment |
US8657852B2 (en) | 2008-10-30 | 2014-02-25 | Abbott Vascular Inc. | Closure device |
US9241696B2 (en) | 2008-10-30 | 2016-01-26 | Abbott Vascular Inc. | Closure device |
US8858594B2 (en) | 2008-12-22 | 2014-10-14 | Abbott Laboratories | Curved closure device |
US9089311B2 (en) | 2009-01-09 | 2015-07-28 | Abbott Vascular Inc. | Vessel closure devices and methods |
US9314230B2 (en) | 2009-01-09 | 2016-04-19 | Abbott Vascular Inc. | Closure device with rapidly eroding anchor |
US10537313B2 (en) | 2009-01-09 | 2020-01-21 | Abbott Vascular, Inc. | Closure devices and methods |
US9173644B2 (en) | 2009-01-09 | 2015-11-03 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US11439378B2 (en) | 2009-01-09 | 2022-09-13 | Abbott Cardiovascular Systems, Inc. | Closure devices and methods |
US9486191B2 (en) | 2009-01-09 | 2016-11-08 | Abbott Vascular, Inc. | Closure devices |
US9414820B2 (en) | 2009-01-09 | 2016-08-16 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US9414824B2 (en) | 2009-01-16 | 2016-08-16 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US20100185234A1 (en) * | 2009-01-16 | 2010-07-22 | Abbott Vascular Inc. | Closure devices, systems, and methods |
US8905937B2 (en) | 2009-02-26 | 2014-12-09 | Integrated Vascular Systems, Inc. | Methods and apparatus for locating a surface of a body lumen |
US9585647B2 (en) | 2009-08-26 | 2017-03-07 | Abbott Laboratories | Medical device for repairing a fistula |
WO2011028310A1 (en) * | 2009-09-02 | 2011-03-10 | Circulite, Inc. | Coaxial transseptal guide-wire and needle assembly |
US20110054487A1 (en) * | 2009-09-02 | 2011-03-03 | Circulite, Inc. | Coaxial transseptal guide-wire and needle assembly |
US8696693B2 (en) * | 2009-12-05 | 2014-04-15 | Integrated Sensing Systems, Inc. | Delivery system, method, and anchor for medical implant placement |
US20120022507A1 (en) * | 2009-12-05 | 2012-01-26 | Integrated Sensing Systems Inc. | Delivery system, method, and anchor for medical implant placement |
US8715300B2 (en) * | 2009-12-05 | 2014-05-06 | Integrated Sensing Systems, Inc. | Delivery system, method, and anchor for medical implant placement |
US20110303229A1 (en) * | 2009-12-05 | 2011-12-15 | Integrated Sensing Systems, Inc. | Delivery system, method, and anchor for medical implant placement |
US9980708B2 (en) | 2010-01-20 | 2018-05-29 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US10058314B2 (en) | 2010-01-20 | 2018-08-28 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US10743854B2 (en) | 2010-01-20 | 2020-08-18 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US9050065B2 (en) | 2010-01-20 | 2015-06-09 | Micro Interventional Devices, Inc. | Tissue repair implant and delivery device and method |
US20110178534A1 (en) * | 2010-01-20 | 2011-07-21 | Whitman Michael P | Tissue repair implant and delivery device and method |
US10959840B2 (en) | 2010-01-20 | 2021-03-30 | Micro Interventional Devices, Inc. | Systems and methods for affixing a prosthesis to tissue |
US20120022586A1 (en) * | 2010-01-20 | 2012-01-26 | Whitman Michael P | Tissue closure device and method |
US9138211B2 (en) | 2010-01-20 | 2015-09-22 | Micro Interventional Devices, Inc. | Tissue repair implant and delivery device and method |
US8764795B2 (en) * | 2010-01-20 | 2014-07-01 | Micro Interventional Devices, Inc. | Tissue closure device and method |
US9427220B2 (en) | 2010-01-20 | 2016-08-30 | Micro Interventional Devices, Inc. | Tissue repair implant and delivery device and method |
US8758399B2 (en) | 2010-08-02 | 2014-06-24 | Abbott Cardiovascular Systems, Inc. | Expandable bioabsorbable plug apparatus and method |
US8603116B2 (en) | 2010-08-04 | 2013-12-10 | Abbott Cardiovascular Systems, Inc. | Closure device with long tines |
US9149276B2 (en) | 2011-03-21 | 2015-10-06 | Abbott Cardiovascular Systems, Inc. | Clip and deployment apparatus for tissue closure |
US9211116B2 (en) | 2011-06-16 | 2015-12-15 | Curaseal Inc. | Fistula treatment devices and related methods |
US9131941B2 (en) | 2011-06-17 | 2015-09-15 | Curaseal Inc. | Fistula treatment devices and methods |
US20130197571A1 (en) * | 2011-08-24 | 2013-08-01 | Cardiapex Ltd. | Minimally invasive surgical techniques |
US9332976B2 (en) | 2011-11-30 | 2016-05-10 | Abbott Cardiovascular Systems, Inc. | Tissue closure device |
US10537312B2 (en) | 2012-12-21 | 2020-01-21 | Abbott Cardiovascular Systems, Inc. | Articulating suturing device |
US9364209B2 (en) | 2012-12-21 | 2016-06-14 | Abbott Cardiovascular Systems, Inc. | Articulating suturing device |
US11672518B2 (en) | 2012-12-21 | 2023-06-13 | Abbott Cardiovascular Systems, Inc. | Articulating suturing device |
US20160015376A1 (en) * | 2014-07-20 | 2016-01-21 | New York University | Anchored suture line, device and method for surgical suturing |
US9775598B2 (en) * | 2014-07-20 | 2017-10-03 | New York University | Anchored suture line, device and method for surgical suturing |
US11304691B2 (en) | 2016-11-13 | 2022-04-19 | Anchora Medical Ltd. | Minimally-invasive tissue suturing device |
US12011160B2 (en) | 2016-11-13 | 2024-06-18 | Anchora Medical Ltd. | Minimally-invasive tissue suturing device |
WO2019232068A1 (en) * | 2018-05-29 | 2019-12-05 | Paul Sorajja | Method and system for closure of cardiovascular apertures |
Also Published As
Publication number | Publication date |
---|---|
US10945716B2 (en) | 2021-03-16 |
US9861347B2 (en) | 2018-01-09 |
US20120197292A1 (en) | 2012-08-02 |
WO2007028092A1 (en) | 2007-03-08 |
CA2621197A1 (en) | 2007-03-08 |
AU2006287211B2 (en) | 2012-09-27 |
AU2006287211A1 (en) | 2007-03-08 |
US20180125470A1 (en) | 2018-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10945716B2 (en) | Patent foramen ovale closure method | |
US8777984B2 (en) | Patent foramen ovale closure device | |
US8834562B2 (en) | Patent foramen ovale closure device with steerable delivery system | |
US8945179B2 (en) | Single disc occlusionary patent foramen ovale closure device | |
US8308759B2 (en) | Single disc intraluminal fixation patent foramen ovale closure device | |
CA2801864C (en) | Patent foramen ovale closure device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CORDIS CORPORATION, NEW JERSEY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CHEN, CHAO-CHIN;GRISHABER, RANDY DAVID B.;KAMMERER, GENE W.;AND OTHERS;SIGNING DATES FROM 20100927 TO 20110210;REEL/FRAME:025794/0813 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |